
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Revolutionizing cardiac fibrosis treatment: the potential of personalized CAR T-cell therapy - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE532CF78AF1FC13052CF7000AADD6BD.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="cardioon">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372244/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Cardio-oncology">
<meta name="citation_title" content="Revolutionizing cardiac fibrosis treatment: the potential of personalized CAR T-cell therapy">
<meta name="citation_author" content="Soroush Taherkhani">
<meta name="citation_author_institution" content="Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Maryam Honardoost">
<meta name="citation_author_institution" content="Cardio-oncology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Negar Dokhani">
<meta name="citation_author_institution" content="Cardio-oncology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Atousa Janzadeh">
<meta name="citation_author_institution" content="Neuromusculoskeletal Research Center, Iran University of Medical Sciences, Tehran, Iran">
<meta name="citation_publication_date" content="2025 Aug 22">
<meta name="citation_volume" content="11">
<meta name="citation_firstpage" content="76">
<meta name="citation_doi" content="10.1186/s40959-025-00367-w">
<meta name="citation_pmid" content="40847431">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372244/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372244/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372244/pdf/40959_2025_Article_367.pdf">
<meta name="description" content="Cardiac fibrosis, a condition characterized by the deposition of excess collagen in the cardiac tissue, is a major complication of various cardiovascular diseases, including myocardial infarction, hypertension, and different types of ...">
<meta name="og:title" content="Revolutionizing cardiac fibrosis treatment: the potential of personalized CAR T-cell therapy">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Cardiac fibrosis, a condition characterized by the deposition of excess collagen in the cardiac tissue, is a major complication of various cardiovascular diseases, including myocardial infarction, hypertension, and different types of ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372244/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12372244">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s40959-025-00367-w"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/40959_2025_Article_367.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372244%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12372244/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12372244/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372244/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cardioon.png" alt="Cardio-oncology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Cardio-oncology" title="Link to Cardio-oncology" shape="default" href="https://cardiooncologyjournal.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cardiooncology</button></div>. 2025 Aug 22;11:76. doi: <a href="https://doi.org/10.1186/s40959-025-00367-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s40959-025-00367-w</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Cardiooncology%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cardiooncology%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cardiooncology%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cardiooncology%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><div class="lang-switcher font-secondary font-xs">
<label>Show available content in</label><ul class="lang-switcher__list">
<li class="lang-switcher__item"><button class="lang-switcher__button" aria-expanded="true" disabled data-lang="en">en</button></li>
<li class="lang-switcher__item"><button class="lang-switcher__button" aria-expanded="false" data-lang="de">de</button></li>
</ul>
</div>
<section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Revolutionizing cardiac fibrosis treatment: the potential of personalized CAR T-cell therapy</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Taherkhani%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Soroush Taherkhani</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Soroush Taherkhani</span></h3>
<div class="p">
<sup>1</sup>Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Taherkhani%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Soroush Taherkhani</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Honardoost%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Maryam Honardoost</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Maryam Honardoost</span></h3>
<div class="p">
<sup>2</sup>Cardio-oncology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Honardoost%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Maryam Honardoost</span></a>
</div>
</div>
<sup>2,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dokhani%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Negar Dokhani</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Negar Dokhani</span></h3>
<div class="p">
<sup>2</sup>Cardio-oncology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dokhani%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Negar Dokhani</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Janzadeh%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Atousa Janzadeh</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Atousa Janzadeh</span></h3>
<div class="p">
<sup>3</sup>Neuromusculoskeletal Research Center, Iran University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Janzadeh%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Atousa Janzadeh</span></a>
</div>
</div>
<sup>3</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran </div>
<div id="Aff2">
<sup>2</sup>Cardio-oncology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran </div>
<div id="Aff3">
<sup>3</sup>Neuromusculoskeletal Research Center, Iran University of Medical Sciences, Tehran, Iran </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Mar 18; Accepted 2025 Jul 10; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12372244  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40847431/" class="usa-link">40847431</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract trans" lang="en" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Cardiac fibrosis, a condition characterized by the deposition of excess collagen in the cardiac tissue, is a major complication of various cardiovascular diseases, including myocardial infarction, hypertension, and different types of cardiomyopathies. CAR T-cell therapy, a form of immunotherapy that involves the genetic modification of T cells to recognize and target specific antigens, has shown promise in the treatment of various cancers and autoimmune diseases. The rationale behind using CAR T-cell therapy to treat cardiac fibrosis lies in the fact that fibrosis is often driven by the activation of pro-fibrotic immune cells, such as myofibroblasts. By targeting these pro-fibrotic cells with CAR T-cells, it may be possible to reduce the severity of cardiac fibrosis. Enhancing CAR T-cell therapy through innovative nanoparticle delivery systems provides a comprehensive approach to treating cardiac fibrosis, with experimental evidence indicating potential in reducing fibrosis and improving cardiac function. Despite these benefits, significant challenges such as cardiotoxicity and cardiovascular complications remain. Therefore, this review explores the molecular mechanisms underlying cardiac fibrosis and the effects of CAR T-cell therapy on the heart, elucidating both its antifibrotic properties and associated cardiotoxic effects based on findings from recent studies.</p></section><section class="abstract trans" hidden="hidden" lang="de" id="Abs2"><h2>Graphical Abstract</h2>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372244_40959_2025_367_Figa_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62b0/12372244/1bf022eb2edb/40959_2025_367_Figa_HTML.jpg" loading="lazy" id="d33e184" height="382" width="669" alt="graphic file with name 40959_2025_367_Figa_HTML.jpg"></a></p>
<section id="kwd-group1" lang="de" class="kwd-group"><p><strong>Keywords:</strong> CAR T-cell therapy, Cardiac fibrosis, Cardio-oncology, Cardiotoxicity</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par3">Collagen is essential for maintaining the structural integrity and function of the heart under healthy conditions. However, in the context of heart disease, the dysregulation of collagen synthesis and deposition can lead to adverse remodeling, impaired cardiac function, and heart failure [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Cardiac fibrosis is considered a type of heart remodeling process. The excessive synthesis and secretion of ECM components, along with ECM-associated modulatory glycoproteins, are hallmark features of fibrosis. This condition is at least partly driven by immune system activation and inflammation that occur following cardiac stress, hypertension, myocardial infarction, chronic inflammation or exposure to various toxic substances [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. While quiescent fibroblasts help preserve the normal architecture of heart muscle, fibroblasts that become pathologically activated due to injury or disease impair the heart’s compliance and increase its stiffness [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. These activated fibroblasts also send signals to cardiac myocytes that further impair myocardial function. Although the fibrotic response serves as a critical barrier against myocardial rupture during infarction, it can lead to adverse remodeling that accelerates the progression of heart failure [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>, <a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>].</p>
<p id="Par4">This process involves post-translational modifications and cross-linking of ECM proteins, as well as the recruitment of fibroblasts that differentiate into myofibroblasts [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Additionally, there is often a dysregulation of ECM degradation, which is mediated by matrix metalloproteinases (MMPs) and their endogenous inhibitors [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. These changes contribute to the pathological remodeling of tissues, leading to increased stiffness and impaired function. As a result, there is a complex interplay between cellular signaling pathways and ECM dynamics in the progression of fibrosis [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>, <a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>].</p>
<p id="Par5">The extent of myocardial fibrosis holds prognostic value, as it leads to contractile dysfunction and arrhythmias in structural heart diseases with diverse etiologies. Unfortunately, there are currently limited effective treatments available for established cardiac fibrosis [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. Myocardial fibrosis is classified into three types: (1) Reactive interstitial fibrosis, linked to hypertension and diabetes, marked by collagen accumulation without injury (2) Infiltrative interstitial fibrosis, associated with storage disorders like amyloidosis; and (3) Reparative fibrosis, which occurs after myocardial infarction and in non-ischemic cardiomyopathies by collagen deposition [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>–<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. During the early stages or upon the removal of underlying causes, cardiac fibrosis may regress, allowing for the restoration of normal tissue structure and function. To facilitate the regression of cardiac fibrosis, various strategies can be employed, including the regulation of myofibroblast activation and proliferation and/ or elimination of fibrogenic myofibroblasts [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>].</p>
<p id="Par6">Despite disappointing outcomes from clinical trials and extensive research on traditional methods aimed at disrupting the inflammation-fibrosis axis, antifibrotic immunotherapy remains a valuable area for future investigation, even after fibrosis and heart failure have developed [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. However, the progress of immunotherapy presents challenges, especially concerning the use of allogeneic T cells, which have shown potential in targeting myofibroblasts and effectively treating cardiac fibrosis [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>].</p>
<p id="Par7">Therapeutic agents prescribed, such as inhibitors of the renin-angiotensin-aldosterone system (RAAS) or Peroxisome proliferator-activated receptor (PPAR-α) agonists, have shown benefits in decreasing fibrosis [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. Despite extensive research, no antifibrotic medication has convincingly demonstrated the ability to reverse fibrosis or improve health outcomes in clinical studies. These findings underscore the need for innovative strategies that focus on targeting myofibroblasts rather than solely addressing individual molecular pathways [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. In this regard, chimeric antigen receptor T-cell (CAR T) therapy presents a promising approach to potentially halt or reverse cardiac fibrosis. CAR T therapy is an advanced form of immunotherapy that involves genetically modifying autologous T cells to specifically target and eliminate surface antigens on affected cells [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. While CAR T-cells have shown significant success in cancer treatment, this technology can be adapted for other medical fields, positioning CAR T immunotherapy as a viable strategy for combating cardiovascular diseases [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. Recent studies have highlighted the effectiveness of CAR T-cell therapy in treating cardiac fibrosis in murine models [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>, <a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. This breakthrough suggests the potential for addressing interstitial fibrosis related to various conditions, including diabetes [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>, <a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>].</p>
<p id="Par8">CAR T-cell therapy involves engineering T cells to express chimeric antigen receptors (CARs) that recognize specific surface proteins on target cells. Upon encountering these target cells, the modified T cells become activated and initiate a cytotoxic response, resulting in the elimination of the targeted cells [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. In the context of cardiac fibrosis, CAR T-cells could be specifically designed to target surface antigens found on fibrogenic myofibroblasts. This targeted approach would allow for the selective removal of these cells, potentially promoting the regression of fibrotic lesions and improving cardiac function [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. However, while this innovative treatment holds promise, it is important to acknowledge the significant risks associated with CAR T-cell therapy. These risks include potential toxicity and adverse effects, which may encompass cardiovascular complications. Therefore, careful consideration and monitoring are essential when implementing this therapy in patients with cardiac fibrosis [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>].</p>
<p id="Par9">There is an ongoing debate regarding the prevalence of cardiotoxicity following CAR T-cell therapy.</p>
<p id="Par10">In this context, we will explore the advantages and challenges of utilizing CAR T-cell therapy for the treatment of cardiac fibrosis.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Molecular mechanism of cardiac fibrosis</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Signaling pathways</h3>
<p id="Par11">Cardiac fibroblasts are primarily responsible for establishing and maintaining the structural framework that upholds the integrity of the heart. They play a vital role in facilitating effective muscle contraction and provide stable anchorage for other cardiac cells, which modulate the activity of cardiomyocytes. Additionally, cardiac fibroblasts support the heart’s architecture by synthesizing collagen, a key component of the extracellular matrix [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>].</p>
<p id="Par12">After heart injury and during tissue remodeling, MMPs enzymes degrade collagen (types I and III) and other extracellular matrix proteins. The activity of MMPs is finely regulated by tissue inhibitors of metalloproteinases (TIMPs), which help maintain the balance between matrix synthesis and degradation. This balance is essential for normal cardiac function, as any disruption can lead to pathological conditions such as fibrosis and heart failure [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>, <a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. Understanding the interactions between cardiac fibroblasts, MMPs, and TIMPs is critical for developing therapeutic strategies aimed at preserving cardiac function and preventing adverse remodeling in various heart diseases. Cardiac fibrosis occurs when the synthesis of ECM proteins exceeds their degradation. This imbalance between ECM production and breakdown can lead to structural changes in cardiac tissue, contributing to impaired heart function [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>].</p>
<p id="Par13">The nature of the initial myocardial injury significantly influences the mechanisms by which fibrogenic signals are activated. Fibroblasts are stimulated through neurohumoral pathways, both directly and indirectly, by their effects on immune cell populations [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. Activation of cardiac fibroblasts occurs in response to various myocardial injuries via well-established mechanisms involving signaling molecules such as Transforming Growth Factor Beta (TGF-β) (Fig. <a href="#Fig1" class="usa-link">1</a>), small mother against decapentaplegic (SMAD) proteins 2/3, interleukins (IL-1, IL-11, IL-14), platelet-derived growth factors (PDGFs), and tumor necrosis factor-alpha (TNF-α), along with other immune system interactions [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>].</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372244_40959_2025_367_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62b0/12372244/6aa46ada10f5/40959_2025_367_Fig1_HTML.jpg" loading="lazy" id="d33e336" height="374" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The molecular mechanisms underlying cardiac fibrosis are complex and involve various cell types and signaling pathways</p></figcaption></figure><p id="Par15">As another involved cascade, the Wnt/Fzd signaling pathway is crucial for regulating fibroblast activation [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. Wnt ligands serve as extracellular signaling molecules that transmit signals through Frizzled (Fzd) receptors or co-receptors LRP5 and LRP6. TGF-β induces pro-fibrotic signaling partially via the Frizzled-8 receptor [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Additionally, elevated levels of Wnt2 and Wnt4 activate β-catenin/NF-κB signaling pathways, facilitating cardiac fibrosis through the collaborative action of Fzd4/2 and LRP6 in fibroblasts.</p>
<p id="Par16">Moreover, matricellular proteins and secreted fibrogenic mediators, including integrins, cytokine receptors, syndecans, and CD44, bind to various fibroblast cell surface receptors. This binding initiates intracellular signaling cascades that regulate genes involved in the synthesis, processing, and metabolism of the ECM [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. Fibrosis not only compromises cardiomyocyte health and function but also leads to increased stiffness of the myocardium. In response to different myocardial injuries, TGF-β-SMAD2/3 pathways activate cardiac fibroblasts, prompting them to produce ECM proteins while simultaneously suppressing immune cell proliferation. Moreover, elevated levels of mediators that stimulate cardiac fibroblast activity, such as angiotensin II (Ang II), aldosterone, and catecholamines, significantly contribute to the development of reactive fibrosis in heart diseases [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>, <a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>, <a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>, <a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>].</p></section><section id="Sec4"><h3 class="pmc_sec_title">Genetic of myocardial fibrosis</h3>
<p id="Par17">The genetic basis of cardiomyopathies includes various variants and mutations in genes related to cell contractility, sarcomere proteins, calcium regulation, cytoskeletal components, and metabolic pathways (Table <a href="#Tab1" class="usa-link">1</a>). These genetic alterations lead to changes in ventricular structure, function, and remodeling [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. In genetic cardiomyopathies, these alterations typically affect the architecture and functionality of cardiomyocytes, often resulting in the development of fibrosis [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. Previous genome-wide association studies (GWAS) have determined variants associated with cardiac structure and dysfunction. Notably, common genetic variations in the SMARCB1 gene have been linked to increased left ventricular wall thickness and enhanced TGF-β1-mediated myocardial fibrosis [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. Other studies have associated genes such as MYH7, MYH6, CDKN1A, SH2B3, TTN, LMNA, and BAG3 with myocardial fibrosis [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>–<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>].</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Genes associated with cardiac fibrosis</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Gene</th>
<th align="left" colspan="1" rowspan="1">Function/Role</th>
<th align="left" colspan="1" rowspan="1">Implication in Fibrosis</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">MYH7</td>
<td align="left" colspan="1" rowspan="1">Sarcomere protein involved in muscle contraction</td>
<td align="left" colspan="1" rowspan="1">Mutations linked to cardiomyopathies and fibrosis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MYBPC3</td>
<td align="left" colspan="1" rowspan="1">Cardiac muscle protein</td>
<td align="left" colspan="1" rowspan="1">Alterations associated with fibrotic response</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">COL1A1</td>
<td align="left" colspan="1" rowspan="1">Collagen type I</td>
<td align="left" colspan="1" rowspan="1">Increased expression contributes to ECM accumulation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">COL3A1</td>
<td align="left" colspan="1" rowspan="1">Collagen type III</td>
<td align="left" colspan="1" rowspan="1">Similar role in ECM deposition</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TGF-β1</td>
<td align="left" colspan="1" rowspan="1">Cytokine regulating fibroblast activity</td>
<td align="left" colspan="1" rowspan="1">Promotes fibroblast activation and collagen synthesis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CTGF</td>
<td align="left" colspan="1" rowspan="1">Connective tissue growth factor</td>
<td align="left" colspan="1" rowspan="1">Enhances TGF-β1 effects, promoting fibrosis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MMPs</td>
<td align="left" colspan="1" rowspan="1">Matrix metalloproteinases</td>
<td align="left" colspan="1" rowspan="1">Involved in ECM remodeling; dysregulation leads to fibrosis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TIMPs</td>
<td align="left" colspan="1" rowspan="1">Tissue inhibitors of metalloproteinases</td>
<td align="left" colspan="1" rowspan="1">Regulate MMP activity; balance is crucial for ECM homeostasis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SOD2</td>
<td align="left" colspan="1" rowspan="1">Antioxidant enzyme</td>
<td align="left" colspan="1" rowspan="1">Dysregulation linked to oxidative stress and fibrosis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">NLRP3</td>
<td align="left" colspan="1" rowspan="1">Inflammasome component</td>
<td align="left" colspan="1" rowspan="1">Associated with inflammation and fibrotic response</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GSK3β</td>
<td align="left" colspan="1" rowspan="1">Protein kinase involved in cell signaling</td>
<td align="left" colspan="1" rowspan="1">Regulates pathways that influence fibroblast activity</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PRKCA</td>
<td align="left" colspan="1" rowspan="1">Protein kinase C alpha</td>
<td align="left" colspan="1" rowspan="1">Promotes fibroblast activation and ECM production</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p id="Par19">Additionally, researchers have indicated that alterations in genes encoding sarcomere protein components, such as MYH7, MYBPC3, and MYL2, are common among a significant proportion of patients exhibiting an inflammatory phenotype accompanied by subsequent fibrosis [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. Phospholamban (PLN), a sarcoplasmic reticulum membrane protein expressed in cardiomyocytes, plays a crucial role in calcium regulation. Skarp et al. demonstrated that hearts with the PLN-R14del variant exhibited the highest levels of myocardial fibrosis. Whole exome sequencing of patients with myocardial fibrosis identified 21 missense variants and one nonsense variant located in genes such as cartilage acidic protein 1 (CRATC1), calpain 1 (CAPN1), unc-45 myosin chaperone A (UNC45A), and unc-45 myosin chaperone B (UNC45B). These variants contribute to the functionality of the extracellular matrix and cardiomyocytes [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>]. Furthermore, 11 independent loci have been associated with T1 time, a marker of myocardial fibrosis. The identified loci implicate genes involved in various biological processes, including glucose transport (SLC2A12), iron homeostasis (HFE, TMPRSS6), tissue repair (ADAMTSL1, VEGFC), oxidative stress response (SOD2 SNP rs9457699_G), cardiac hypertrophy (MYH7B), and calcium signaling (CAMK2D, rs55754224_T), all of which are linked to myocardial fibrosis [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>].</p>
<p id="Par20">Studies have suggested that genetic predispositions can interact with lifestyle factors such as diet and exercise, further influencing the risk of developing cardiac fibrosis. Identifying specific genetic markers associated with increased susceptibility to fibrosis could pave the way for personalized treatment approaches and targeted therapies aimed at mitigating the progression of cardiac diseases [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>, <a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>].</p></section><section id="Sec5"><h3 class="pmc_sec_title">Epigenetic modulation of cardiac fibrosis</h3>
<p id="Par21">Environmental factors such as hypertension, diabetes, and oxidative stress can induce epigenetic changes that contribute to cardiac fibrosis. These stressors lead to persistent alterations in gene expression profiles, promoting fibrotic processes [<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. Epigenetic modulation significantly influences the pathogenesis of cardiac fibrosis by affecting gene expression patterns related to fibroblast activation and ECM accumulation. This modulation involves changes in histones and DNA, as well as the role of non-coding RNAs. Cardiac fibrosis is characterized by excessive ECM accumulation in the heart, resulting in stiffness and impaired function, highlighting the importance of understanding these epigenetic mechanisms [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>].</p>
<p id="Par22">Fibrosis is linked to elevated levels of DNA methylation. Specifically, cardiac fibroblasts (CFs) show increased DNA methylation when exposed to ischemic conditions that drive cardiac fibrosis. This phenomenon is associated with the upregulation of the DNA methyltransferases DNMT1, DNMT3a, and DNMT3b [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>].</p>
<p id="Par23">DNMT3a plays a vital role in facilitating fibroblast activation through the extracellular signal-regulated kinase 1/2 (ERK1/2) signaling pathway, promoting cardiac fibrosis by inducing abnormal methylation of the Ras protein activator-like-1 (Rasal-1) and Ras-association domain family 1 (Rassf-1) (Fig. <a href="#Fig2" class="usa-link">2</a>). This process results in increased methylation and the production of fibrosis-related markers, such as α-SMA. For instance, the H3K4me3 epigenetic mark, indicative of histone modifications, has been observed to be upregulated in the promoter region of the pro-fibrotic gene Smad3 following TGF-β stimulation in cardiac fibroblasts [<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>, <a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>]. The involvement of histone acetyltransferases, particularly CBP/P300, in cardiac fibrosis is well documented, as they act as coactivators within the TGF-β signaling pathway and with the Smad3 transcription factor, thereby epigenetically modulating the expression of collagen-related pro-fibrotic genes [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>].</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372244_40959_2025_367_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62b0/12372244/d73e688fbb23/40959_2025_367_Fig2_HTML.jpg" loading="lazy" id="d33e548" height="376" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Epigenetic modifiers can either activate or repress gene expression by targeting DNA and/or RNA, thereby influencing cellular fate</p></figcaption></figure><p id="Par25">Additionally, Ang II has been shown to enhance the expression of the endothelin-1 (ET-1) gene in endothelial cells by depositing the H3K4me3 mark on the ET-1 promoter, which subsequently contributes to the formation of fibrotic tissue in the murine heart [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>]. Furthermore, there is increasing evidence linking the expression of specific microRNAs, such as miR-133a, miR-208, miR-1, and miR-451, with the onset and progression of cardiac fibrosis. Emerging therapies targeting epigenetic factors to modulate antifibrotic mechanisms in the remodeling of fibrotic heart tissue may represent the future of treatment approaches for cardiac fibrosis [<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>–<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>].</p></section></section><section id="Sec6"><h2 class="pmc_sec_title">CAR T-cell therapy for cardiac fibrosis</h2>
<p id="Par26">CAR T-cells are typically generated by introducing a genetically modified CAR fusion protein into a patient’s T cells. Following this modification, the T cells are expanded and subsequently infused into the patient after a lymphodepletion process [<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>]. Post-infusion, these T cells undergo proliferation and identify their target antigen, leading to the activation of endogenous T cells and the release of cytokines that facilitate the destruction of target cells. Selecting the appropriate cell-surface target for CAR T-cells is essential and can differ across various organs and species. To reduce ‘off-target’ impacts on healthy tissues, the optimal target should be limited to the affected tissue, where fibrogenesis is predominantly observed [<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>, <a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>].</p>
<p id="Par27">Fibroblast activation protein (FAP), identified as an endogenous target for cardiac fibrosis, was revealed through the expression analysis of gene profiles from cardiac fibroblasts in both healthy and diseased human hearts. This gene exhibited the greatest variation between control and diseased samples [<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>]. FAP is a cell surface glycoprotein that is typically expressed at low levels or is absent in most normal adult mice or human tissues. It is expressed during embryonic development at sites undergoing active tissue remodeling, such as wound repair, tissue fibrosis, and various tumors [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. This glycoprotein plays a significant role in the degradation of extracellular matrix components, including collagen. By cleaving collagen and other ECM proteins, FAP facilitates tissue remodeling, which is essential during normal healing processes but can contribute to pathological fibrosis when dysregulated [<a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>]. In diseases characterized by excessive fibrosis (e.g., cardiac fibrosis, liver cirrhosis), this may contribute to the accumulation of collagen, leading to tissue stiffness and dysfunction [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>]. Previous studies have noted that human hearts with acute myocardial infarction injury express FAP at elevated levels, while healthy human hearts exhibit minimal FAP expression [<a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>]. Therefore, targeting FAP could potentially modulate collagen metabolism and serve as a therapeutic strategy in fibrotic diseases [<a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>–<a href="#CR71" class="usa-link" aria-describedby="CR71">71</a>].</p>
<p id="Par28">FAP CAR T-cells are generated by isolating and engineering CD8 + T lymphocytes to express a segment of a single-chain variable fragment (scFv) that specifically recognizes FAP. This scFv is fused to the cytoplasmic domains of human CD3ζ and CD28, which are essential for T cell activation and proliferation [<a href="#CR72" class="usa-link" aria-describedby="CR72">72</a>]. Once infused into the patient, these CAR T-cells migrate to the heart, where they selectively target myofibroblasts or activated fibroblasts that express FAP. Upon recognising it in these cells, the CAR T-cells utilize cytotoxic mechanisms to induce apoptosis in the myofibroblasts, thereby inhibiting the fibrotic process [<a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>]. This targeted approach, which aims at reparative fibroblasts, raises significant concerns regarding potential off-target effects during tissue healing, particularly after an acute myocardial infarction (AMI). The sustained presence of CAR T-cells may lead to the depletion of reparative fibroblasts long after their beneficial functions have ceased, resulting in detrimental long-term cardiac remodeling. Targeting FAP-expressing cells in the aftermath of AMI could obstruct the essential fibrotic response, potentially causing severe structural failure of the infarcted myocardium. Research conducted in murine models indicates that the depletion of activated fibroblasts can hinder scar formation and elevate mortality rates following cardiac injury [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>].</p>
<p id="Par29">This highlights the dual role of fibrosis as both a pathological and protective mechanism. Temporary CAR T approaches, including RNA-based CAR-Ts or switchable CAR-Ts, present a viable solution by restricting the duration of fibroblast depletion. RNA CAR-Ts transiently express the receptor and are degraded within days, creating a limited period of activity [<a href="#CR75" class="usa-link" aria-describedby="CR75">75</a>]. Alternatively, synthetic “on/off” switches or suicide gene systems can allow clinicians to regulate the lifespan of CAR T-cells [<a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>].</p>
<p id="Par30">Previous studies have demonstrated the effectiveness of using CAR T-cells targeting FAP to ablate tumor-promoting cancer-associated stromal cells and treatment of mesothelioma and pancreatic cancer. The efficacy of ex-vivo CAR T-cells in selectively targeting and eliminating myofibroblasts within a mouse model [<a href="#CR77" class="usa-link" aria-describedby="CR77">77</a>, <a href="#CR78" class="usa-link" aria-describedby="CR78">78</a>]. In the AngII/PE mouse model of hypertensive cardiac injury and fibrosis, adoptive transfer of T lymphocytes expressing a CAR against FAP significantly reduced cardiac fibrosis and partially restored both diastolic and systolic function after cardiac injury in mice. These findings provide proof-of-concept for a novel immunotherapeutic approach to treating heart disease [<a href="#CR79" class="usa-link" aria-describedby="CR79">79</a>].</p>
<section id="Sec7"><h3 class="pmc_sec_title">Cardio safety and scalability</h3>
<p id="Par31">Given the significant improvements that CAR T-cells have demonstrated in treating myocardial fibrosis, minimizing toxic effects will be crucial for their successful application in humans. Currently, the primary methods for generating CAR-engineered T cells involve viral gene transduction using retroviral or lentiviral vectors. These methods risk insertional mutagenesis and genotoxic effects in the effector cells [<a href="#CR80" class="usa-link" aria-describedby="CR80">80</a>]. Additionally, the prolonged protein expression enabled by these viral vectors could result in uncontrolled adverse outcomes if significant toxicities arise due to unintended cross-reactivity [<a href="#CR81" class="usa-link" aria-describedby="CR81">81</a>]. Therefore, developing safer gene delivery methods and refining CAR T-cell design will be essential to enhance their therapeutic potential while mitigating risks [<a href="#CR82" class="usa-link" aria-describedby="CR82">82</a>]. Furthermore, in contrast to cancer, where the advantages of immune surveillance and the sustained presence of targeted T cells are crucial for completely eradicating cancer cells, fibrotic disorders require merely a general decrease in disease burden to realize clinical improvements [<a href="#CR83" class="usa-link" aria-describedby="CR83">83</a>].</p>
<p id="Par32">Another challenge associated with the prolonged activation of CAR T-cells is the treatment of human diseases linked to fibrosis, as activated fibroblasts play a crucial role in the wound healing process [<a href="#CR84" class="usa-link" aria-describedby="CR84">84</a>]. When chimeric antigen receptor T cells are modified through conventional methods to target fibroblasts, they may persist in the body for several months or even years. This extended presence could potentially hinder the wound-healing process over time [<a href="#CR85" class="usa-link" aria-describedby="CR85">85</a>]. In this context, patients with heart failure who have persistent CAR T-cells used to manage chronic fibrosis may face an increased risk of complications, such as cardiac ventricular wall rupture, particularly in the event of a subsequent myocardial infarction [<a href="#CR86" class="usa-link" aria-describedby="CR86">86</a>]. Therefore, it is essential to develop strategies that allow for the controlled activation and eventual deactivation of CAR T-cells, ensuring that their therapeutic effects do not compromise critical healing processes in the heart and other tissues. Additionally, alternative approaches that target fibrosis without long-term T cell persistence may be necessary to mitigate these risks [<a href="#CR87" class="usa-link" aria-describedby="CR87">87</a>].</p>
<section id="Sec8"><h4 class="pmc_sec_title">mRNA- lipid nanoparticles technology</h4>
<p id="Par33">To reduce the disadvantage of permanent activation CAR T-cells, nucleoside-modified mRNA technology was developed as a temporary CAR T-cell therapy. The transient nature of the RNA by methylation to reduce immunogenic responses technique, which offers a safety advantage over prolonged CAR T-cell therapy, is an important advancement of the CAR T generation method [<a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>]. Using this method, it is possible to generate a short-lived CAR T-cell without the need for a viral vector or the risk of genomic integration by modifying the cells to express messenger RNA rather than virally encoded DNA [<a href="#CR89" class="usa-link" aria-describedby="CR89">89</a>]. After cellular uptake, the mRNA escapes the endosome and is quickly translated before being degraded in the cytoplasm. Additionally, the expression of the CAR ceases once the mRNA degrades or becomes diluted due to cell division. This transient nature of CAR expression is crucial for minimizing potential adverse effects while still allowing for effective cellular responses during the therapeutic process [<a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>, <a href="#CR91" class="usa-link" aria-describedby="CR91">91</a>]. To overcome the mentioned challenges as well as to eliminate the necessity for T cell extraction and reinfusion, the latest advancement in antifibrosis CAR T-cell production is the use of lipid nanoparticles (LNPs) carrying FAP mRNA sequences, while they were coated with an anti-CD5 antibody to facilitate their targeting to T cells, when injected intravenously [<a href="#CR92" class="usa-link" aria-describedby="CR92">92</a>]. The in-vivo administration of the LNP-mRNA system facilitates the endocytosis of the lipid nanoparticles, leading to their degradation and subsequent release of mRNA into the cytoplasm of T cells. This mRNA is unable to integrate into the genome and has a short half-life [<a href="#CR93" class="usa-link" aria-describedby="CR93">93</a>]. According to Rurik et al., the delivery of LNPs to T cells led to a temporary expression of FAPCAR, which enabled the CAR T-cells to specifically eliminate FAP<sup>+</sup> fibroblasts, thereby reducing fibrosis in a mouse model subjected to cardiac stress through Ang II and PE infusion and improving cardiac function. Similar to virally engineered FAP CAR T-cells [<a href="#CR94" class="usa-link" aria-describedby="CR94">94</a>], these LNP-generated CAR T-cells were able to efficiently kill FAP-expressing target cells in vitro in a dose-dependent manner (Fig. <a href="#Fig3" class="usa-link">3</a>).</p>
<figure class="fig xbox font-sm" id="Fig3"><h5 class="obj_head">Fig. 3.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372244_40959_2025_367_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62b0/12372244/c1f191d53b46/40959_2025_367_Fig3_HTML.jpg" loading="lazy" id="d33e700" height="373" width="669" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The generation of CAR T-cells in vivo using CD5/LNP-FAPCAR involves administering LNP coated with anti-CD5 antibodies along with mRNA that encodes the FAPCAR membrane receptor. This approach enables the production of transient CAR T-cells that specifically target and eliminate pro-fibrotic cells in the damaged myocardium. The FAPCAR membrane receptor is designed to recognize the FAP protein expressed by cardiac myofibroblasts</p></figcaption></figure><p id="Par35">The use of this technology in mRNA vaccines against COVID-19 (BNT162b2 and mRNA-1273) has demonstrated its safety and scalability [<a href="#CR95" class="usa-link" aria-describedby="CR95">95</a>]. Significant efforts are needed to establish the appropriate dosage strategy for effectively eliminating cardiac fibrosis, given the distinct characteristics of COVID-19 infection compared to other cardiovascular diseases [<a href="#CR96" class="usa-link" aria-describedby="CR96">96</a>]. However, the application of transient CAR T reprogramming offers the potential for controlled “dosing” of cells. This approach requires a comprehensive analysis of the proliferation and expansion kinetics of fibroblasts in various fibrotic disease contexts where this technology may be utilized [<a href="#CR97" class="usa-link" aria-describedby="CR97">97</a>]. For example, fibroblast proliferation rates in response to cardiac stress can vary significantly and are closely associated with other tissue responses, such as inflammation and vascular remodeling [<a href="#CR98" class="usa-link" aria-describedby="CR98">98</a>]. Furthermore, the plasticity and differentiation states of activated fibroblasts can be affected by the nature and duration of the injury [<a href="#CR99" class="usa-link" aria-describedby="CR99">99</a>].</p></section><section id="Sec9"><h4 class="pmc_sec_title">Epigenetic modification of CAR T-cells</h4>
<p id="Par36">The application of epigenetic mechanisms and modifications presents another promising approach to address the challenges associated with CAR T-cell therapy improvement. Epigenetic modifications serve as a mechanism to influence gene expression through chromatin remodeling, which is facilitated by various histone modifiers, including post-translational modifications such as acetylation, methylation, phosphorylation, ubiquitination, SUMOylation, and lactylation [<a href="#CR100" class="usa-link" aria-describedby="CR100">100</a>]. Additionally, DNA methyltransferases (DNMTs) and ten-eleven translocation (TET) enzymes, which are involved in demethylation, along with non-coding RNAs like microRNAs, play crucial roles in this process. These epigenetic modifiers can either activate or repress gene expression by targeting DNA and/or RNA, thereby influencing cellular fate [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>].</p>
<p id="Par37">In the context of CAR T-cells, strategic epigenetic modifications can mitigate the obstacles that hinder their effectiveness. Such modifications can enhance the persistence and survival of T cells, reduce T cell exhaustion, improve their infiltration into tumor sites, and promote the development of a memory phenotype [<a href="#CR101" class="usa-link" aria-describedby="CR101">101</a>]. Selective epigenetic reprogramming can generate less differentiated CAR T-cells, potentially reducing CAR T-cell exhaustion. “Less differentiated CAR T-cells” are in an earlier stage of development, resembling naïve or memory T cells rather than fully matured effector T cells. These cells are often preferred for therapy as they persist longer, proliferate more effectively upon encountering tumor antigens, show less exhaustion, and are linked to better long-term outcomes and durable responses [<a href="#CR102" class="usa-link" aria-describedby="CR102">102</a>]. The ongoing evolution of CAR T technology, alongside the technical challenges faced, aims to enhance the therapeutic efficacy of CAR T-cell therapy, particularly in the field of cardio-oncology [<a href="#CR103" class="usa-link" aria-describedby="CR103">103</a>].</p></section></section></section><section id="Sec10"><h2 class="pmc_sec_title">CRS and cardiotoxicity; the main CAR T-cell therapy issue</h2>
<p id="Par38">The activation and proliferation of CAR T-cells often lead to a significant release of inflammatory cytokines, which can have a profound impact on cardiac function. This process is known as cytokine release syndrome (CRS) [<a href="#CR104" class="usa-link" aria-describedby="CR104">104</a>]. When CAR T-cells become activated, they secrete various inflammatory cytokines and chemokines, including IL-1, IL-6, IL-1Ra, and CC-chemokine ligands CCL2 and CCL3, as well as nitric oxide (NO). Additionally, bystander immune cells contribute to this inflammatory response by releasing IL-6, soluble IL-6 receptor (sIL-6R), IL-2, interferon-gamma, and granulocyte-macrophage colony-stimulating factor (GM-CSF) [<a href="#CR105" class="usa-link" aria-describedby="CR105">105</a>, <a href="#CR106" class="usa-link" aria-describedby="CR106">106</a>]. Among these, IL-6 plays a critical role in mediating toxicity during CRS by the recruitment of additional T cells by increasing the expression of chemokine’s that attract them and facilitates the differentiation of lymphocytes [<a href="#CR107" class="usa-link" aria-describedby="CR107">107</a>]. Moreover, IL-6 activates the gp130/STAT3 signaling pathway, which exacerbates oxidative stress and contributes to mitochondrial dysfunction and cardiac hypertrophy [<a href="#CR108" class="usa-link" aria-describedby="CR108">108</a>]. Elevated levels of reactive oxygen species contribute to increased apoptosis in cardiomyocytes. Additionally, IL-6 alters calcium handling and reduces myocardial contractility, potentially leading to diastolic dysfunction and arrhythmias [<a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>].</p>
<p id="Par39">Patients undergoing CAR T-cell therapy experience a range of symptoms associated with CRS, including fever, myalgia, fatigue, hypotension, tachycardia, and capillary leakage. Cardiotoxicity related to CRS can range from arrhythmias and hemodynamic instability due to hypotension, to left ventricular (LV) dysfunction and even sudden cardiac death [<a href="#CR110" class="usa-link" aria-describedby="CR110">110</a>]. The severity of CRS, particularly grade 3 CRS, which includes temperature abnormalities, hypotension requiring vasopressors, and hypoxia that demands the use of high-flow nasal cannula or non-rebreather masks, has been significantly correlated with the development of adverse cardiovascular events in patients undergoing CAR T treatment [<a href="#CR111" class="usa-link" aria-describedby="CR111">111</a>].</p>
<p id="Par40">Retrospective cohort studies have shown that major adverse cardiovascular events (MACE) occurred in 10–20% of patients [<a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>]. In contrast, a meta-analysis found a higher prevalence of cardiotoxic effects: 54% of patients experienced arrhythmias, 30% developed heart failure, 20% showed signs of cardiomyopathy, 10% suffered from acute coronary syndrome (ACS), and 7% experienced cardiac arrest. These discrepancies underscore the need for more extensive, long-term cohort studies to fully evaluate the cardiotoxicity associated with CAR T-cell therapy [<a href="#CR112" class="usa-link" aria-describedby="CR112">112</a>].</p>
<p id="Par41">Patients experience a range of symptoms of CRS with different severity, such as fever, myalgia, fatigue, hypotension, tachycardia, and capillary leakage. Cardiotoxicity secondary to CRS ranges from arrhythmias and hemodynamic instability due to hypotension, left ventricular (LV) dysfunction, to sudden cardiac death [<a href="#CR110" class="usa-link" aria-describedby="CR110">110</a>]. The degree of CRS, particularly grade 3 CRS (presence of temperature abnormalities and hypotension that necessitate the administration of vasopressors, as well as hypoxia that demands the use of high-flow nasal cannula, nonrebreather masks, or Venturi masks), has been found to be significantly correlated with the development of adverse cardiovascular events in retrospective evaluations of individuals undergoing CAR T treatment [<a href="#CR111" class="usa-link" aria-describedby="CR111">111</a>].</p>
<p id="Par42">In a small number of retrospective analyses, severe cardiac dysfunction has been observed in approximately 5–12% of CAR T-cell treated cancer patients, most of whom develop CRS grade 3 [<a href="#CR113" class="usa-link" aria-describedby="CR113">113</a>]. The underlying pathophysiology is not fully understood, but it has been suggested that the myocardium and conduction system are dysfunctional due to systemic cytokines, similar to what occurs in septic environments. Pharmacovigilance data recently showed that the relative mortality of patients with CV and pulmonary adverse events (CPAEs) in CAR T-cell therapy was 30.9%, while the relative mortality of patients with CRS was 17.4%. This highlights the urgent need to address these issues [<a href="#CR114" class="usa-link" aria-describedby="CR114">114</a>].</p>
<p id="Par43">Cardiotoxicity is a serious complication that occurs early after CAR T-cell administration, typically within the first two weeks. The incidence of death attributed to cardiotoxicity ranged from 1.4 to 4.3%. The mechanisms of cardiotoxicity of CAR T-cell therapies are thought to be primarily caused by CRS-associated systemic inflammation [<a href="#CR115" class="usa-link" aria-describedby="CR115">115</a>].</p>
<p id="Par44">Cardiovascular side effects, including cardiac arrhythmias (such as atrial fibrillation, supraventricular tachycardia (SVT), atrioventricular nodal block, prolonged QT interval, and sinus and ventricular tachycardia), left ventricular dysfunction (LVD), HF, pericardial effusion, and, in rare cases, cardiac arrest, have been reported following CAR T-cell therapy [<a href="#CR116" class="usa-link" aria-describedby="CR116">116</a>].</p>
<p id="Par45">Clinical observations, including those from Phase I-III trials, show that CV side effects are common in patients receiving CAR T-cell therapy, with a decline in left ventricular ejection fraction (LVEF) observed in 10–30% of cases. These side effects are also associated with significant morbidity and mortality [<a href="#CR117" class="usa-link" aria-describedby="CR117">117</a>].</p>
<p id="Par46">Arrhythmias (incidence ranging from 5 to 12%), cardiomyopathy/heart failure, cerebrovascular accidents (CVAs), and myocardial infarction (MI) are examples of serious adverse cardiovascular events [<a href="#CR118" class="usa-link" aria-describedby="CR118">118</a>]. Within thirty days of receiving CAR T-cell therapy, 16% of patients experienced at least one MACE. However, the range of clinical symptoms is broad. It can include decompensated heart failure, new-onset arrhythmias, left ventricular systolic function (LVSD), elevated serum troponin levels, sinus tachycardia (often associated with CRS fever), and cardiovascular mortality. To date, LVSD associated with CAR T-cell therapy has been shown to be reversible at 6 months in the setting of physiologic stress resulting from CRS [<a href="#CR119" class="usa-link" aria-describedby="CR119">119</a>, <a href="#CR120" class="usa-link" aria-describedby="CR120">120</a>].</p>
<p id="Par47">The treatment of cardiovascular problems after CAR T-cell therapy depends on the specific issue and the patient’s status, as most cardiovascular complications arise from CRS [<a href="#CR111" class="usa-link" aria-describedby="CR111">111</a>]. BP monitoring is crucial to recognize hypotension and to prescribe IV fluids or vasopressors when needed. Additionally, using drugs that suppress CRS toxicity after CAR T-cell therapy, such as Tocilizumab, Siltuximab, or corticosteroids, is important [<a href="#CR121" class="usa-link" aria-describedby="CR121">121</a>, <a href="#CR122" class="usa-link" aria-describedby="CR122">122</a>]. A study found that vasopressors were used for 13.6% of patients with hypotension following CD19 CAR T-cell therapy for lymphoma [<a href="#CR123" class="usa-link" aria-describedby="CR123">123</a>]. If a patient develops AF, which is common due to CRS, its management follows current guidelines and includes the need for anticoagulation, monitoring of electrolyte levels, antiarrhythmic therapy, or cardioversion [<a href="#CR124" class="usa-link" aria-describedby="CR124">124</a>]. Studies have shown that having preexisting cardiac disease increases the risk of cardiovascular disorders after CAR T-cell therapy [<a href="#CR125" class="usa-link" aria-describedby="CR125">125</a>]. Evaluating patients prior to CAR T is a crucial step, and this assessment should be conducted by a cardio-oncologist, including cardiac biomarkers, echocardiography, ECG, or examination, depending on the patient’s baseline disease and medical history. A study showed that a global longitudinal strain (GLS) measured by echocardiography six months prior to CAR T-cell therapy was associated with a higher risk of cardiovascular events after CAR T [<a href="#CR126" class="usa-link" aria-describedby="CR126">126</a>].</p>
<section id="Sec11"><h3 class="pmc_sec_title">Cardiotoxicity biomarkers pre CAR T-cell therapy</h3>
<p id="Par48">Retrospective observational studies have reported a significant cardiovascular event rate ranging from 12 to 28% among patients undergoing CAR T-cell therapy, with most of these events occurring shortly after treatment, typically within 6 to 21 days post-transfusion [<a href="#CR127" class="usa-link" aria-describedby="CR127">127</a>]. Early detection of cardiac injury and inflammatory responses is crucial, as it allows for timely interventions that can include dose adjustments and the initiation of cardio protective therapies. By implementing proactive monitoring strategies, healthcare providers can better manage potential complications and improve patient outcomes following CAR T-cell therapy [<a href="#CR124" class="usa-link" aria-describedby="CR124">124</a>]. Research on biomarkers that predict cardiotoxicity associated with CAR T-cell therapy remains limited, leaving the roles of cardiac and inflammatory biomarkers in managing this cardiotoxicity insufficiently understood. However, cytokines have emerged as some of the most potent and accessible laboratory biomarkers for predicting CRS [<a href="#CR128" class="usa-link" aria-describedby="CR128">128</a>]. Several predictive biomarkers, including interferon-gamma, IL-6, soluble gp130 (sgp130), soluble IL-6 receptor (sIL-6R), and IL-15, have been studied in patients [<a href="#CR129" class="usa-link" aria-describedby="CR129">129</a>]. Research indicates that peak levels of interferon-gamma, IL-6, and IL-15 are correlated with the onset of atrial fibrillation following CAR T-cell infusion [<a href="#CR111" class="usa-link" aria-describedby="CR111">111</a>]. Additionally, elevated levels of high-sensitivity troponin T (hsTropT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) can help identify patients at high risk for cardiac events after CAR T-cell infusion. These findings underscore the importance of monitoring these biomarkers to better manage potential cardiotoxicity in affected patients. Elevation in troponin levels may indicate myocardial damage, similar to their role in ischemic cardiomyopathy, while increases in N-terminal pro-B-type natriuretic peptide (NT-proBNP) may serve as a marker for cardiac stress, akin to its use in heart failure [<a href="#CR130" class="usa-link" aria-describedby="CR130">130</a>].</p>
<p id="Par49">Published data have shown a correlation between troponin elevation and the occurrence of CRS of grade 2 or higher, which is associated with a decrease in LVEF and an increased risk of serious cardiovascular adverse events in patients with elevated troponin levels [<a href="#CR120" class="usa-link" aria-describedby="CR120">120</a>]. Furthermore, these biomarkers can provide critical insights into patient management following CAR T-cell therapy. Monitoring troponin and NT-proBNP levels can facilitate early identification of cardiac complications, allowing for timely interventions to mitigate risks and improve patient outcomes. Elevated troponin levels indicate myocardial injury, while high NT-proBNP levels reflect increased cardiac stress, both of which are essential for assessing cardiovascular health in this patient population [<a href="#CR131" class="usa-link" aria-describedby="CR131">131</a>, <a href="#CR132" class="usa-link" aria-describedby="CR132">132</a>].</p>
<p id="Par50">In contrast, Hu JR et al. found that troponin-T levels did not change during CAR T-cell therapy, while NT-proBNP levels were elevated. However, the authors did not establish a correlation between these findings and cardiotoxicity [<a href="#CR133" class="usa-link" aria-describedby="CR133">133</a>]. Neither cardiac nor pro-inflammatory cytokines were associated with cardiac events following CAR T-cell therapy; rather, clinical factors such as age, baseline creatinine levels, and left atrial volume were identified as significant predictors of these events. Hence, more research is needed to clarify the role of pro-inflammatory cytokines and cardiac biomarker monitoring in patients receiving CAR T-cell therapy [<a href="#CR107" class="usa-link" aria-describedby="CR107">107</a>].</p></section></section><section id="Sec12"><h2 class="pmc_sec_title">Pre CAR T-cell cardiovascular management</h2>
<p id="Par51">The latest guidelines from the European Society of Cardiology (ESC) on cardio-oncology recommend that all cancer patients undergo a baseline electrocardiogram (ECG), along with measurements of natriuretic peptides (NP) and cardiac troponin (cTn), prior to receiving CAR T-cell therapy [<a href="#CR134" class="usa-link" aria-describedby="CR134">134</a>]. For patients with pre-existing cardiovascular conditions, an echocardiogram is advised. Furthermore, the guidelines suggest that NP and cTn levels should be monitored, along with echocardiography, in patients experiencing CRS of grade 2 or lower. Grade 2 CRS is characterized by fever (≥ 38.0 °C) accompanied by hypotension that does not require vasopressor support and/or hypoxia necessitating supplemental oxygen via low-flow nasal cannula (≤ 6 L/min) or equivalent. [<a href="#CR116" class="usa-link" aria-describedby="CR116">116</a>].</p>
<p id="Par52">For the best possible management of the cardiovascular consequences of CAR T-cell therapy, interdisciplinary collaboration between oncologists, neurologists, pharmacists, specialized nurses, and cardio-oncologists with competence in critical care is required [<a href="#CR135" class="usa-link" aria-describedby="CR135">135</a>]. Cardio-oncology evaluation will be required prior to initiation of CAR T-cell therapy if the patient has abnormalities in their biomarkers or cardiac diagnostic tests. [<a href="#CR136" class="usa-link" aria-describedby="CR136">136</a>]. A suggested evaluation for patients with a history of cardiovascular symptoms, abnormal echocardiogram or ECG, pre-existing CVD, or reduced exercise tolerance includes consultation with a cardio-oncologist and diagnostic testing based on the patient’s risk factors [<a href="#CR137" class="usa-link" aria-describedby="CR137">137</a>].</p>
<p id="Par53">Patients with pre-existing arrhythmias or coronary artery disease, a history of chemotherapy-induced cardiomyopathy or other cardiomyopathies, or a high risk of coronary artery disease based on their calculated QRISK3-2018 score are all included in high-risk category [<a href="#CR138" class="usa-link" aria-describedby="CR138">138</a>]. All patients suggested undergo a 12-lead ECG, cardiac imaging with TTE (including 2-, 3- and 4-dimensional assessment of left ventricular ejection fraction, diastolic and global longitudinal strain), CMR with a fast scan protocol, and blood sampling for troponin and NT-proBNP levels to inform clinical decisions in cardio-oncology and help identify the occurrence of a CV adverse event during cancer therapy. GLS should be assessed by echocardiography as it has been shown to decrease after CAR T-cell therapy [<a href="#CR139" class="usa-link" aria-describedby="CR139">139</a>].</p>
<p id="Par54">To address the very sensitive early phase, a standardized cardio-oncology follow-up with biomarkers, echocardiography and ECG performed on day 7 after CAR T-cell transfusion may be helpful. For high-risk patients, a 3-month follow-up with cardiac biomarkers, ECG, and echocardiography is recommended to evaluate any recovery of overt CV symptoms or delayed CV damage [<a href="#CR140" class="usa-link" aria-describedby="CR140">140</a>].</p></section><section id="Sec13"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par55">CAR T-cell therapy presents significant potential benefits for treating cardiac fibrosis. This innovative approach allows for targeted therapy, selectively attacking pro-fibrotic immune cells while preserving non-fibrotic cells, which enhances both safety and efficacy. Additionally, CAR T-cell therapy can be personalized to meet the specific needs of individual patients, tailoring the treatment to optimize outcomes. It also offers the possibility of being used as an adjunct therapy, combining with pharmacological agents or stem cell treatments for a more comprehensive strategy against cardiac fibrosis. However, challenges such as the high cost of CAR T-cell therapy may limit its widespread application. There is increasing interest in exploring CAR T-cell therapy’s potential for other cardiovascular diseases, like atherosclerosis and cardiac remodeling, which could lead to novel therapies targeting various aspects of cardiovascular health. Despite these advantages, understanding the complex adverse effects associated with CAR T-cell therapy is still in its early stages. The efficacy and safety of this treatment modality require validation through specialized clinical trials. A critical future focus for cardio-oncology will be managing cardiovascular events effectively while maintaining anti-cancer efficacy. Improved clinical management strategies will emerge from a deeper understanding of the molecular mechanisms underlying cardiotoxicity, potentially validating CAR T-cell therapy as a viable option and paving the way for new therapeutic paradigms in cardiovascular disease. Additionally, addressing the epigenetic dysregulation observed in patient-derived T cells is vital for developing fully functional CAR T-cells with enhanced activity. Mapping the epigenome of these cells may help reprogram them into effective therapeutic agents. This can be achieved through DNA methylation and hydroxymethylation, histone modifications such as methylation, acetylation, and phosphorylation, as well as non-coding RNA-mediated mechanisms including miRNAs, lncRNAs, and siRNAs [<a href="#CR141" class="usa-link" aria-describedby="CR141">141</a>]. Using allogeneic CAR T-cells from healthy donors could also be a promising strategy to overcome existing limitations.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Non to report.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>S.T: literature search, writing and figures design; N.D; literature search, writing; A. J: literature search, writing and manuscript reviewing; M.H: Had the idea, writing and manuscript reviewing.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>Non to report.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>No datasets were generated or analysed during the current study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar3"><h3 class="pmc_sec_title">Ethical approval and consent to participate</h3>
<p id="Par56">Not applicable.</p></section><section id="FPar1"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par57">Not applicable.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par58">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci. 2014;71:549–74.
</cite> [<a href="https://doi.org/10.1007/s00018-013-1349-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3769482/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23649149/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kong%20P,%20Christia%20P,%20Frangogiannis%20NG.%20The%20pathogenesis%20of%20cardiac%20fibrosis.%20Cell%20Mol%20Life%20Sci.%202014;71:549%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Hinderer S, Schenke-Layland K. Cardiac fibrosis–a short review of causes and therapeutic strategies. Adv Drug Deliv Rev. 2019;146:77–82.
</cite> [<a href="https://doi.org/10.1016/j.addr.2019.05.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31158407/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hinderer%20S,%20Schenke-Layland%20K.%20Cardiac%20fibrosis%E2%80%93a%20short%20review%20of%20causes%20and%20therapeutic%20strategies.%20Adv%20Drug%20Deliv%20Rev.%202019;146:77%E2%80%9382." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC. Cardiac fibrosis: the fibroblast awakens. Circul Res. 2016;118(6):1021–40.</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.115.306565" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4800485/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26987915/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Travers%20JG,%20Kamal%20FA,%20Robbins%20J,%20Yutzey%20KE,%20Blaxall%20BC.%20Cardiac%20fibrosis:%20the%20fibroblast%20awakens.%20Circul%20Res.%202016;118(6):1021%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Ma ZG, Yuan YP, Wu HM, Zhang X, Tang QZ. Cardiac fibrosis: new insights into the pathogenesis. Int J Biol Sci. 2018;14(12):1645.
</cite> [<a href="https://doi.org/10.7150/ijbs.28103" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6216032/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30416379/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ma%20ZG,%20Yuan%20YP,%20Wu%20HM,%20Zhang%20X,%20Tang%20QZ.%20Cardiac%20fibrosis:%20new%20insights%20into%20the%20pathogenesis.%20Int%20J%20Biol%20Sci.%202018;14(12):1645." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Park S, Nguyen NB, Pezhouman A, Ardehali R. Cardiac fibrosis: potential therapeutic targets. Translational Res. 2019;209:121–37.</cite> [<a href="https://doi.org/10.1016/j.trsl.2019.03.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6545256/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30930180/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Park%20S,%20Nguyen%20NB,%20Pezhouman%20A,%20Ardehali%20R.%20Cardiac%20fibrosis:%20potential%20therapeutic%20targets.%20Translational%20Res.%202019;209:121%E2%80%9337." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Krenning G, Zeisberg EM, Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol. 2010;225(3):631–7.
</cite> [<a href="https://doi.org/10.1002/jcp.22322" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3098503/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20635395/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Krenning%20G,%20Zeisberg%20EM,%20Kalluri%20R.%20The%20origin%20of%20fibroblasts%20and%20mechanism%20of%20cardiac%20fibrosis.%20J%20Cell%20Physiol.%202010;225(3):631%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Frangogiannis NG. Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol Aspects Med. 2019;65:70–99.
</cite> [<a href="https://doi.org/10.1016/j.mam.2018.07.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30056242/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Frangogiannis%20NG.%20Cardiac%20fibrosis:%20cell%20biological%20mechanisms,%20molecular%20pathways%20and%20therapeutic%20opportunities.%20Mol%20Aspects%20Med.%202019;65:70%E2%80%9399." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Maruyama K, Imanaka-Yoshida K. The pathogenesis of cardiac fibrosis: a review of recent progress. Int J Mol Sci. 2022;23(5):2617.
</cite> [<a href="https://doi.org/10.3390/ijms23052617" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8910720/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35269759/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maruyama%20K,%20Imanaka-Yoshida%20K.%20The%20pathogenesis%20of%20cardiac%20fibrosis:%20a%20review%20of%20recent%20progress.%20Int%20J%20Mol%20Sci.%202022;23(5):2617." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Fan Z, Guan J. Antifibrotic therapies to control cardiac fibrosis. Biomaterials Res. 2016;20(1):13.</cite> [<a href="https://doi.org/10.1186/s40824-016-0060-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4879750/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27226899/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fan%20Z,%20Guan%20J.%20Antifibrotic%20therapies%20to%20control%20cardiac%20fibrosis.%20Biomaterials%20Res.%202016;20(1):13." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Leask A. Getting to the heart of the matter: new insights into cardiac fibrosis. Circul Res. 2015;116(7):1269–76.</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.116.305381" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25814687/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Leask%20A.%20Getting%20to%20the%20heart%20of%20the%20matter:%20new%20insights%20into%20cardiac%20fibrosis.%20Circul%20Res.%202015;116(7):1269%E2%80%9376." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Li L, Zhao Q, Kong W. Extracellular matrix remodeling and cardiac fibrosis. Matrix Biol. 2018;68:490–506.
</cite> [<a href="https://doi.org/10.1016/j.matbio.2018.01.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29371055/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20L,%20Zhao%20Q,%20Kong%20W.%20Extracellular%20matrix%20remodeling%20and%20cardiac%20fibrosis.%20Matrix%20Biol.%202018;68:490%E2%80%93506." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Nguyen MN, Kiriazis H, Gao XM, Du XJ. Cardiac fibrosis and arrhythmogenesis. Compr Physiol. 2011;7(3):1009–49.</cite> [<a href="https://doi.org/10.1002/cphy.c160046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28640451/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nguyen%20MN,%20Kiriazis%20H,%20Gao%20XM,%20Du%20XJ.%20Cardiac%20fibrosis%20and%20arrhythmogenesis.%20Compr%20Physiol.%202011;7(3):1009%E2%80%9349." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Sohns C, Marrouche NF. Atrial fibrillation and cardiac fibrosis. Eur Heart J. 2020;41(10):1123–31.
</cite> [<a href="https://doi.org/10.1093/eurheartj/ehz786" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31713590/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sohns%20C,%20Marrouche%20NF.%20Atrial%20fibrillation%20and%20cardiac%20fibrosis.%20Eur%20Heart%20J.%202020;41(10):1123%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Talman V, Ruskoaho H. Cardiac fibrosis in myocardial infarction—from repair and remodeling to regeneration. Cell Tissue Res. 2016;365:563–81.
</cite> [<a href="https://doi.org/10.1007/s00441-016-2431-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5010608/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27324127/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Talman%20V,%20Ruskoaho%20H.%20Cardiac%20fibrosis%20in%20myocardial%20infarction%E2%80%94from%20repair%20and%20remodeling%20to%20regeneration.%20Cell%20Tissue%20Res.%202016;365:563%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Aghajanian H, Kimura T, Rurik JG, Hancock AS, Leibowitz MS, Li L, Epstein JA. Targeting cardiac fibrosis with engineered T cells. Nature. 2019;573(7774):430–3.
</cite> [<a href="https://doi.org/10.1038/s41586-019-1546-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6752964/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31511695/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Aghajanian%20H,%20Kimura%20T,%20Rurik%20JG,%20Hancock%20AS,%20Leibowitz%20MS,%20Li%20L,%20Epstein%20JA.%20Targeting%20cardiac%20fibrosis%20with%20engineered%20T%20cells.%20Nature.%202019;573(7774):430%E2%80%933." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Vagnozzi RJ, Johansen AK, Molkentin JD. CARdiac immunotherapy: T cells engineered to treat the fibrotic heart. Mol Therapy. 2019;27(11):1869–71.</cite> [<a href="https://doi.org/10.1016/j.ymthe.2019.09.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6838878/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31585799/" class="usa-link">PubMed</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Vagnozzi RJ, McKinsey TA. T cell immunotherapy for cardiac fibrosis: mRNA starts the CAR. Cell Stem Cell. 2022;29(3):352–4. </cite> [<a href="https://doi.org/10.1016/j.stem.2022.02.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35245466/" class="usa-link">PubMed</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Liu M, de Juan Abad BL, Cheng K. Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies. Adv Drug Deliv Rev. 2021;173:504–19.
</cite> [<a href="https://doi.org/10.1016/j.addr.2021.03.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8299409/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33831476/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20M,%20de%20Juan%20Abad%20BL,%20Cheng%20K.%20Cardiac%20fibrosis:%20Myofibroblast-mediated%20pathological%20regulation%20and%20drug%20delivery%20strategies.%20Adv%20Drug%20Deliv%20Rev.%202021;173:504%E2%80%9319." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Ishikane S, Arioka M, Takahashi-Yanaga F. Promising small molecule anti-fibrotic agents: newly developed or repositioned drugs targeting myofibroblast transdifferentiation. Biochem Pharmacol. 2023;214:115663.</cite> [<a href="https://doi.org/10.1016/j.bcp.2023.115663" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37336252/" class="usa-link">PubMed</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Maher TM, Strek ME. Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat. Respir Res. 2019;20(1):205.</cite> [<a href="https://doi.org/10.1186/s12931-019-1161-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6731623/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31492155/" class="usa-link">PubMed</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Liuzzo G, Patrono C. In vivo generated chimeric antigen receptor T cells reduce fibrosis and restore cardiac function in experimental heart failure. 2002</cite> [<a href="https://doi.org/10.1093/eurheartj/ehac090" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35187570/" class="usa-link">PubMed</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Zhang Q, Dai J, Liu T, Rao W, Li D, Gu Z, Hou X. Targeting cardiac fibrosis with chimeric antigen Receptor-Engineered cells. Mol Cell Biochem. 2024;1–14.</cite> [<a href="https://doi.org/10.1007/s11010-024-05134-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39460827/" class="usa-link">PubMed</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Aghajanian H, Kimura T, Rurik JG, Hancock AS, Leibowitz MS, Li L, Scholler J, Monslow J, Lo A, Han W, Wang T. Targeting cardiac fibrosis with engineered T cells. Nature. 2019;573(7774):430–3.
</cite> [<a href="https://doi.org/10.1038/s41586-019-1546-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6752964/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31511695/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Aghajanian%20H,%20Kimura%20T,%20Rurik%20JG,%20Hancock%20AS,%20Leibowitz%20MS,%20Li%20L,%20Scholler%20J,%20Monslow%20J,%20Lo%20A,%20Han%20W,%20Wang%20T.%20Targeting%20cardiac%20fibrosis%20with%20engineered%20T%20cells.%20Nature.%202019;573(7774):430%E2%80%933." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Ferrer-Curriu G, Soler-Botija C, Charvatova S, Motais B, Roura S, Galvez-Monton C, Monguió-Tortajada M, Iborra-Egea O, Emdin M, Lupón J, Aimo A. Preclinical scenario of targeting myocardial fibrosis with chimeric antigen receptor (CAR) immunotherapy. Biomed Pharmacother. 2023;158:114061.
</cite> [<a href="https://doi.org/10.1016/j.biopha.2022.114061" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36495661/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ferrer-Curriu%20G,%20Soler-Botija%20C,%20Charvatova%20S,%20Motais%20B,%20Roura%20S,%20Galvez-Monton%20C,%20Mongui%C3%B3-Tortajada%20M,%20Iborra-Egea%20O,%20Emdin%20M,%20Lup%C3%B3n%20J,%20Aimo%20A.%20Preclinical%20scenario%20of%20targeting%20myocardial%20fibrosis%20with%20chimeric%20antigen%20receptor%20(CAR)%20immunotherapy.%20Biomed%20Pharmacother.%202023;158:114061." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Zhang L, Sosinowski T, Cox AR, Cepeda JR, Sekhar NS, Hartig SM, Miao D, Yu L, Pietropaolo M, Davidson HW. Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II: peptide complex modulate the progression of autoimmune diabetes. J Autoimmun. 2019;96:50–8.
</cite> [<a href="https://doi.org/10.1016/j.jaut.2018.08.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6541442/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30122420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20L,%20Sosinowski%20T,%20Cox%20AR,%20Cepeda%20JR,%20Sekhar%20NS,%20Hartig%20SM,%20Miao%20D,%20Yu%20L,%20Pietropaolo%20M,%20Davidson%20HW.%20Chimeric%20antigen%20receptor%20(CAR)%20T%20cells%20targeting%20a%20pathogenic%20MHC%20class%20II:%20peptide%20complex%20modulate%20the%20progression%20of%20autoimmune%20diabetes.%20J%20Autoimmun.%202019;96:50%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Mohammadi V, Maleki AJ, Nazari M, Siahmansouri A, Moradi A, Elahi R, Esmaeilzadeh A. Chimeric antigen receptor (CAR)-based cell therapy for type 1 diabetes mellitus (T1DM); current progress and future approaches. Stem Cell Reviews Rep. 2024;20(3):585–600.</cite> [<a href="https://doi.org/10.1007/s12015-023-10668-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38153634/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mohammadi%20V,%20Maleki%20AJ,%20Nazari%20M,%20Siahmansouri%20A,%20Moradi%20A,%20Elahi%20R,%20Esmaeilzadeh%20A.%20Chimeric%20antigen%20receptor%20(CAR)-based%20cell%20therapy%20for%20type%201%20diabetes%20mellitus%20(T1DM);%20current%20progress%20and%20future%20approaches.%20Stem%20Cell%20Reviews%20Rep.%202024;20(3):585%E2%80%93600." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Wang X, Wu X, Tan B, Zhu L, Zhang Y, Lin L, Xu H. Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis. Cell. 2024;187(18):4890–904.
</cite> [<a href="https://doi.org/10.1016/j.cell.2024.06.027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39013470/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20X,%20Wu%20X,%20Tan%20B,%20Zhu%20L,%20Zhang%20Y,%20Lin%20L,%20Xu%20H.%20Allogeneic%20CD19-targeted%20CAR-T%20therapy%20in%20patients%20with%20severe%20myositis%20and%20systemic%20sclerosis.%20Cell.%202024;187(18):4890%E2%80%93904." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Gao TA, Chen YY. T cells to fix a broken heart. Science. 2022;375(6576):23–4.
</cite> [<a href="https://doi.org/10.1126/science.abn0851" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34990255/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gao%20TA,%20Chen%20YY.%20T%20cells%20to%20fix%20a%20broken%20heart.%20Science.%202022;375(6576):23%E2%80%934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Patel NP, Doukas PG, Gordon LI, Akhter N. Cardiovascular toxicities of CAR T-cell therapy. Curr Oncol Rep. 2021;23:1–0.</cite> [<a href="https://doi.org/10.1007/s11912-021-01068-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33937946/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Patel%20NP,%20Doukas%20PG,%20Gordon%20LI,%20Akhter%20N.%20Cardiovascular%20toxicities%20of%20CAR%20T-cell%20therapy.%20Curr%20Oncol%20Rep.%202021;23:1%E2%80%930." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Bertaud A, Joshkon A, Heim X, Bachelier R, Bardin N, Leroyer AS, Blot-Chabaud M. Signaling pathways and potential therapeutic strategies in cardiac fibrosis. Int J Mol Sci. 2023;24(2):1756.
</cite> [<a href="https://doi.org/10.3390/ijms24021756" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9866199/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36675283/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bertaud%20A,%20Joshkon%20A,%20Heim%20X,%20Bachelier%20R,%20Bardin%20N,%20Leroyer%20AS,%20Blot-Chabaud%20M.%20Signaling%20pathways%20and%20potential%20therapeutic%20strategies%20in%20cardiac%20fibrosis.%20Int%20J%20Mol%20Sci.%202023;24(2):1756." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Eijgenraam TR, Silljé HH, de Boer RA. Current Understanding of fibrosis in genetic cardiomyopathies. Trends Cardiovasc Med. 2020;30(6):353–61.
</cite> [<a href="https://doi.org/10.1016/j.tcm.2019.09.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31585768/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Eijgenraam%20TR,%20Sillj%C3%A9%20HH,%20de%20Boer%20RA.%20Current%20Understanding%20of%20fibrosis%20in%20genetic%20cardiomyopathies.%20Trends%20Cardiovasc%20Med.%202020;30(6):353%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Cowling RT, Kupsky D, Kahn AM, Daniels LB, Greenberg BH. Mechanisms of cardiac collagen deposition in experimental models and human disease. Translational Res. 2019;209:138–55.</cite> [<a href="https://doi.org/10.1016/j.trsl.2019.03.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6996650/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30986384/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cowling%20RT,%20Kupsky%20D,%20Kahn%20AM,%20Daniels%20LB,%20Greenberg%20BH.%20Mechanisms%20of%20cardiac%20collagen%20deposition%20in%20experimental%20models%20and%20human%20disease.%20Translational%20Res.%202019;209:138%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Qin W, Cao L, Massey IY. Role of PI3K/Akt signaling pathway in cardiac fibrosis. Mol Cell Biochem. 2021;476(11):4045–59.
</cite> [<a href="https://doi.org/10.1007/s11010-021-04219-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34244974/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qin%20W,%20Cao%20L,%20Massey%20IY.%20Role%20of%20PI3K/Akt%20signaling%20pathway%20in%20cardiac%20fibrosis.%20Mol%20Cell%20Biochem.%202021;476(11):4045%E2%80%9359." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Tao H, Yang JJ, Shi KH, Li J. Wnt signaling pathway in cardiac fibrosis: new insights and directions. Metabolism. 2016;65(2):30–40.
</cite> [<a href="https://doi.org/10.1016/j.metabol.2015.10.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26773927/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tao%20H,%20Yang%20JJ,%20Shi%20KH,%20Li%20J.%20Wnt%20signaling%20pathway%20in%20cardiac%20fibrosis:%20new%20insights%20and%20directions.%20Metabolism.%202016;65(2):30%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Matsumori A. Nuclear factor-κB is a prime candidate for the diagnosis and control of inflammatory cardiovascular disease. Eur Cardiol Rev. 2023;18:e40. Article e40 View in Scopus.</cite> [<a href="https://doi.org/10.15420/ecr.2023.10" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10345985/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37456770/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Matsumori%20A.%20Nuclear%20factor-%CE%BAB%20is%20a%20prime%20candidate%20for%20the%20diagnosis%20and%20control%20of%20inflammatory%20cardiovascular%20disease.%20Eur%20Cardiol%20Rev.%202023;18:e40.%20Article%20e40%20View%20in%20Scopus." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Yousefi F, Shabaninejad Z, Vakili S, Derakhshan M, Movahedpour A, Dabiri H, Hamblin MR. TGF-β and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus. Cell Communication Signal. 2020;18:1–16.</cite> [<a href="https://doi.org/10.1186/s12964-020-00555-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7281690/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32517807/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yousefi%20F,%20Shabaninejad%20Z,%20Vakili%20S,%20Derakhshan%20M,%20Movahedpour%20A,%20Dabiri%20H,%20Hamblin%20MR.%20TGF-%CE%B2%20and%20WNT%20signaling%20pathways%20in%20cardiac%20fibrosis:%20non-coding%20RNAs%20come%20into%20focus.%20Cell%20Communication%20Signal.%202020;18:1%E2%80%9316." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Delaunay M, Osman H, Kaiser S, Diviani D. The role of Cyclic AMP signaling in cardiac fibrosis. Cells. 2019;9(1):69.
</cite> [<a href="https://doi.org/10.3390/cells9010069" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7016856/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31888098/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Delaunay%20M,%20Osman%20H,%20Kaiser%20S,%20Diviani%20D.%20The%20role%20of%20Cyclic%20AMP%20signaling%20in%20cardiac%20fibrosis.%20Cells.%202019;9(1):69." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Aguado-Alvaro LP, Garitano N, Pelacho B. Fibroblast diversity and epigenetic regulation in cardiac fibrosis. Int J Mol Sci. 2024;25(11):6004.
</cite> [<a href="https://doi.org/10.3390/ijms25116004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11172550/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38892192/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Aguado-Alvaro%20LP,%20Garitano%20N,%20Pelacho%20B.%20Fibroblast%20diversity%20and%20epigenetic%20regulation%20in%20cardiac%20fibrosis.%20Int%20J%20Mol%20Sci.%202024;25(11):6004." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Gao L, Wang LY, Liu ZQ, Jiang D, Wu SY, Guo YQ, Zhang DY. TNAP Inhibition attenuates cardiac fibrosis induced by myocardial infarction through deactivating TGF-β1/Smads and activating P53 signaling pathways. Cell Death Dis. 2020;11(1):44.
</cite> [<a href="https://doi.org/10.1038/s41419-020-2243-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6976710/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31969558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gao%20L,%20Wang%20LY,%20Liu%20ZQ,%20Jiang%20D,%20Wu%20SY,%20Guo%20YQ,%20Zhang%20DY.%20TNAP%20Inhibition%20attenuates%20cardiac%20fibrosis%20induced%20by%20myocardial%20infarction%20through%20deactivating%20TGF-%CE%B21/Smads%20and%20activating%20P53%20signaling%20pathways.%20Cell%20Death%20Dis.%202020;11(1):44." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Hanna A, Humeres C, Frangogiannis NG. The role of Smad signaling cascades in cardiac fibrosis. Cell Signal. 2021;77:109826.
</cite> [<a href="https://doi.org/10.1016/j.cellsig.2020.109826" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7727442/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33160018/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hanna%20A,%20Humeres%20C,%20Frangogiannis%20NG.%20The%20role%20of%20Smad%20signaling%20cascades%20in%20cardiac%20fibrosis.%20Cell%20Signal.%202021;77:109826." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Parichatikanond W, Luangmonkong T, Mangmool S, Kurose H. Therapeutic targets for the treatment of cardiac fibrosis and cancer: focusing on TGF-β signaling. Front Cardiovasc Med. 2020;7:34.
</cite> [<a href="https://doi.org/10.3389/fcvm.2020.00034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7075814/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32211422/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Parichatikanond%20W,%20Luangmonkong%20T,%20Mangmool%20S,%20Kurose%20H.%20Therapeutic%20targets%20for%20the%20treatment%20of%20cardiac%20fibrosis%20and%20cancer:%20focusing%20on%20TGF-%CE%B2%20signaling.%20Front%20Cardiovasc%20Med.%202020;7:34." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Liu Y, Zhu H, Su Z, Sun C, Yin J, Yuan H, Xu H. IL-17 contributes to cardiac fibrosis following experimental autoimmune myocarditis by a PKCβ/Erk1/2/NF-κB-dependent signaling pathway. Int Immunol. 2012;24(10):605–12.
</cite> [<a href="https://doi.org/10.1093/intimm/dxs056" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22531062/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20Y,%20Zhu%20H,%20Su%20Z,%20Sun%20C,%20Yin%20J,%20Yuan%20H,%20Xu%20H.%20IL-17%20contributes%20to%20cardiac%20fibrosis%20following%20experimental%20autoimmune%20myocarditis%20by%20a%20PKC%CE%B2/Erk1/2/NF-%CE%BAB-dependent%20signaling%20pathway.%20Int%20Immunol.%202012;24(10):605%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Shabani M, Dutta D, Ambale-Venkatesh B, Post WS, Taylor KD, Rich SS, Lima JA. Rare genetic variants associated with myocardial fibrosis: multi-ethnic study of atherosclerosis. Front Cardiovasc Med. 2022;9:804788.
</cite> [<a href="https://doi.org/10.3389/fcvm.2022.804788" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8899004/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35265679/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shabani%20M,%20Dutta%20D,%20Ambale-Venkatesh%20B,%20Post%20WS,%20Taylor%20KD,%20Rich%20SS,%20Lima%20JA.%20Rare%20genetic%20variants%20associated%20with%20myocardial%20fibrosis:%20multi-ethnic%20study%20of%20atherosclerosis.%20Front%20Cardiovasc%20Med.%202022;9:804788." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Sygitowicz G, Maciejak-Jastrzębska A, Sitkiewicz D. A review of the molecular mechanisms underlying cardiac fibrosis and atrial fibrillation. J Clin Med. 2021;10(19):4430.
</cite> [<a href="https://doi.org/10.3390/jcm10194430" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8509789/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34640448/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sygitowicz%20G,%20Maciejak-Jastrz%C4%99bska%20A,%20Sitkiewicz%20D.%20A%20review%20of%20the%20molecular%20mechanisms%20underlying%20cardiac%20fibrosis%20and%20atrial%20fibrillation.%20J%20Clin%20Med.%202021;10(19):4430." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Shabani M, Wang M, Jenkins GD, Rotter JI, Rich SS, Batzler A, Pereira NL. Myocardial fibrosis and cardiomyopathy risk: A genetic link in the MESA. Circulation: Heart Fail 2023;16(9):e010262.</cite> [<a href="https://doi.org/10.1161/CIRCHEARTFAILURE.122.010262" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10602591/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37526028/" class="usa-link">PubMed</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Li X, Li L, Lei W, Chua HZ, Li Z, Huang X, Zhang H. Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanisms. Biomed Pharmacother. 2021;142:111979.</cite> [<a href="https://doi.org/10.1016/j.biopha.2021.111979" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34358754/" class="usa-link">PubMed</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Skarp S, Doedens A, Holmström L, Izzi V, Saarimäki S, Sliz E, Junttila J. Novel genetic variants associated with primary myocardial fibrosis in sudden cardiac death victims. J Cardiovasc Transl Res. 2024;1–11.</cite> [<a href="https://doi.org/10.1007/s12265-024-10527-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11634914/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38848015/" class="usa-link">PubMed</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Nauffal V, Di Achille P, Klarqvist MD, Cunningham JW, Hill MC, Pirruccello JP, Lubitz SA. Genetics of myocardial interstitial fibrosis in the human heart and association with disease. Nat Genet. 2023;55(5):777–86.
</cite> [<a href="https://doi.org/10.1038/s41588-023-01371-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11107861/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37081215/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nauffal%20V,%20Di%20Achille%20P,%20Klarqvist%20MD,%20Cunningham%20JW,%20Hill%20MC,%20Pirruccello%20JP,%20Lubitz%20SA.%20Genetics%20of%20myocardial%20interstitial%20fibrosis%20in%20the%20human%20heart%20and%20association%20with%20disease.%20Nat%20Genet.%202023;55(5):777%E2%80%9386." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Cavalera M, Wang J, Frangogiannis NG. Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities. Translational Res. 2014;164(4):323–35.</cite> [<a href="https://doi.org/10.1016/j.trsl.2014.05.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4180761/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24880146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cavalera%20M,%20Wang%20J,%20Frangogiannis%20NG.%20Obesity,%20metabolic%20dysfunction,%20and%20cardiac%20fibrosis:%20pathophysiological%20pathways,%20molecular%20mechanisms,%20and%20therapeutic%20opportunities.%20Translational%20Res.%202014;164(4):323%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Lu L, Guo J, Hua Y, Huang K, Magaye R, Cornell J, Wang BH. Cardiac fibrosis in the ageing heart: contributors and mechanisms. Clin Exp Pharmacol Physiol. 2017;44:55–63.
</cite> [<a href="https://doi.org/10.1111/1440-1681.12753" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28316086/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lu%20L,%20Guo%20J,%20Hua%20Y,%20Huang%20K,%20Magaye%20R,%20Cornell%20J,%20Wang%20BH.%20Cardiac%20fibrosis%20in%20the%20ageing%20heart:%20contributors%20and%20mechanisms.%20Clin%20Exp%20Pharmacol%20Physiol.%202017;44:55%E2%80%9363." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Zhang S, Weinheimer C, Courtois M, Kovacs A, Zhang CE, Cheng AM, Muslin AJ. The role of the Grb2–p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. J Clin Investig. 2003;111(6):833–41.
</cite> [<a href="https://doi.org/10.1172/JCI16290" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC153766/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12639989/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20S,%20Weinheimer%20C,%20Courtois%20M,%20Kovacs%20A,%20Zhang%20CE,%20Cheng%20AM,%20Muslin%20AJ.%20The%20role%20of%20the%20Grb2%E2%80%93p38%20MAPK%20signaling%20pathway%20in%20cardiac%20hypertrophy%20and%20fibrosis.%20J%20Clin%20Investig.%202003;111(6):833%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Yang W, Wu Z, Yang K, Han Y, Chen Y, Zhao W, Jin W. BMI1 promotes cardiac fibrosis in ischemia-induced heart failure via the PTEN-PI3K/Akt-mTOR signaling pathway. Am J Physiol Heart Circ Physiol. 2019;316(1):H61–9.
</cite> [<a href="https://doi.org/10.1152/ajpheart.00487.2018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30359076/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20W,%20Wu%20Z,%20Yang%20K,%20Han%20Y,%20Chen%20Y,%20Zhao%20W,%20Jin%20W.%20BMI1%20promotes%20cardiac%20fibrosis%20in%20ischemia-induced%20heart%20failure%20via%20the%20PTEN-PI3K/Akt-mTOR%20signaling%20pathway.%20Am%20J%20Physiol%20Heart%20Circ%20Physiol.%202019;316(1):H61%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Grimaldi V, De Pascale MR, Zullo A, Soricelli A, Infante T, Mancini FP, Napoli C. Evidence of epigenetic tags in cardiac fibrosis. J Cardiol. 2017;69(2):401–8.
</cite> [<a href="https://doi.org/10.1016/j.jjcc.2016.10.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27863907/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Grimaldi%20V,%20De%20Pascale%20MR,%20Zullo%20A,%20Soricelli%20A,%20Infante%20T,%20Mancini%20FP,%20Napoli%20C.%20Evidence%20of%20epigenetic%20tags%20in%20cardiac%20fibrosis.%20J%20Cardiol.%202017;69(2):401%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Li Z, Zhu S, Liu Q, Wei J, Jin Y, Wang X, Zhang L. Polystyrene microplastics cause cardiac fibrosis by activating Wnt/β-catenin signaling pathway and promoting cardiomyocyte apoptosis in rats. Environ Pollut. 2020;265:115025.
</cite> [<a href="https://doi.org/10.1016/j.envpol.2020.115025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32806417/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20Z,%20Zhu%20S,%20Liu%20Q,%20Wei%20J,%20Jin%20Y,%20Wang%20X,%20Zhang%20L.%20Polystyrene%20microplastics%20cause%20cardiac%20fibrosis%20by%20activating%20Wnt/%CE%B2-catenin%20signaling%20pathway%20and%20promoting%20cardiomyocyte%20apoptosis%20in%20rats.%20Environ%20Pollut.%202020;265:115025." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Improta-Caria AC, Rodrigues LF, Joaquim VHA, De Sousa RAL, Fernandes T, Oliveira EM. MicroRNAs regulating signaling pathways in cardiac fibrosis: potential role of the exercise training. Am J Physiol Heart Circ Physiol. 2024;326(3):H497–510.
</cite> [<a href="https://doi.org/10.1152/ajpheart.00410.2023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11219062/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38063810/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Improta-Caria%20AC,%20Rodrigues%20LF,%20Joaquim%20VHA,%20De%20Sousa%20RAL,%20Fernandes%20T,%20Oliveira%20EM.%20MicroRNAs%20regulating%20signaling%20pathways%20in%20cardiac%20fibrosis:%20potential%20role%20of%20the%20exercise%20training.%20Am%20J%20Physiol%20Heart%20Circ%20Physiol.%202024;326(3):H497%E2%80%93510." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Xiao H, Ma X, Feng W, Fu Y, Lu Z, Xu M, Zhang Y. Metformin attenuates cardiac fibrosis by inhibiting the TGFβ1–Smad3 signalling pathway. Cardiovascular Res. 2010;87(3):504–13.</cite> [<a href="https://doi.org/10.1093/cvr/cvq066" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20200042/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xiao%20H,%20Ma%20X,%20Feng%20W,%20Fu%20Y,%20Lu%20Z,%20Xu%20M,%20Zhang%20Y.%20Metformin%20attenuates%20cardiac%20fibrosis%20by%20inhibiting%20the%20TGF%CE%B21%E2%80%93Smad3%20signalling%20pathway.%20Cardiovascular%20Res.%202010;87(3):504%E2%80%9313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Zhao J, Chen Y, Chen Q, Hong T, Zhong Z, He J, Ni C. Curcumin ameliorates cardiac fibrosis by regulating macrophage-fibroblast crosstalk via IL18-P-SMAD2/3 signaling pathway Inhibition. Front Pharmacol. 2022;12:784041.
</cite> [<a href="https://doi.org/10.3389/fphar.2021.784041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8804383/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35115932/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20J,%20Chen%20Y,%20Chen%20Q,%20Hong%20T,%20Zhong%20Z,%20He%20J,%20Ni%20C.%20Curcumin%20ameliorates%20cardiac%20fibrosis%20by%20regulating%20macrophage-fibroblast%20crosstalk%20via%20IL18-P-SMAD2/3%20signaling%20pathway%20Inhibition.%20Front%20Pharmacol.%202022;12:784041." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Yue Y, Meng K, Pu Y, Zhang X. Transforming growth factor beta (TGF-β) mediates cardiac fibrosis and induces diabetic cardiomyopathy. Diabetes Res Clin Pract. 2017;133:124–30.
</cite> [<a href="https://doi.org/10.1016/j.diabres.2017.08.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28934669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yue%20Y,%20Meng%20K,%20Pu%20Y,%20Zhang%20X.%20Transforming%20growth%20factor%20beta%20(TGF-%CE%B2)%20mediates%20cardiac%20fibrosis%20and%20induces%20diabetic%20cardiomyopathy.%20Diabetes%20Res%20Clin%20Pract.%202017;133:124%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Cheng X, Wang L, Wen X, Gao L, Li G, Chang G, et al. TNAP is a novel regulator of cardiac fibrosis after myocardial infarction by mediating TGF-β/Smads and ERK1/2 signaling pathways. EBioMedicine 2021;67.</cite> [<a href="https://doi.org/10.1016/j.ebiom.2021.103370" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8122000/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33971401/" class="usa-link">PubMed</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Li R, Frangogiannis NG. Integrins in cardiac fibrosis. J Mol Cell Cardiol. 2022;172:1–13.
</cite> [<a href="https://doi.org/10.1016/j.yjmcc.2022.07.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35872324/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20R,%20Frangogiannis%20NG.%20Integrins%20in%20cardiac%20fibrosis.%20J%20Mol%20Cell%20Cardiol.%202022;172:1%E2%80%9313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Gu X, Jiang YN, Wang WJ, Zhang J, Shang DS, Sun CB, Zhang Y. Comprehensive circrna expression profile and construction of circrna-related CeRNA network in cardiac fibrosis. Biomed Pharmacother. 2020;125:109944.
</cite> [<a href="https://doi.org/10.1016/j.biopha.2020.109944" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32062386/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gu%20X,%20Jiang%20YN,%20Wang%20WJ,%20Zhang%20J,%20Shang%20DS,%20Sun%20CB,%20Zhang%20Y.%20Comprehensive%20circrna%20expression%20profile%20and%20construction%20of%20circrna-related%20CeRNA%20network%20in%20cardiac%20fibrosis.%20Biomed%20Pharmacother.%202020;125:109944." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Bergmann C, Müller F, Distler JH, Györfi AH, Völkl S, Aigner M, Schett G. Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells. Ann Rheum Dis. 2023;82(8):1117–20.
</cite> [<a href="https://doi.org/10.1136/ard-2023-223952" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10359520/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37147112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bergmann%20C,%20M%C3%BCller%20F,%20Distler%20JH,%20Gy%C3%B6rfi%20AH,%20V%C3%B6lkl%20S,%20Aigner%20M,%20Schett%20G.%20Treatment%20of%20a%20patient%20with%20severe%20systemic%20sclerosis%20(SSc)%20using%20CD19-targeted%20CAR%20T%20cells.%20Ann%20Rheum%20Dis.%202023;82(8):1117%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Dalal PJ, Patel NP, Feinstein MJ, Akhter N. Adverse cardiac effects of car t-cell therapy: characteristics, surveillance, management, and future research directions. Technol Cancer Res Treat. 2022;21:15330338221132927.
</cite> [<a href="https://doi.org/10.1177/15330338221132927" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9580078/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36254553/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dalal%20PJ,%20Patel%20NP,%20Feinstein%20MJ,%20Akhter%20N.%20Adverse%20cardiac%20effects%20of%20car%20t-cell%20therapy:%20characteristics,%20surveillance,%20management,%20and%20future%20research%20directions.%20Technol%20Cancer%20Res%20Treat.%202022;21:15330338221132927." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Amrute JM, Luo X, Penna V, Yang S, Yamawaki T, Hayat S, et al. Targeting immune–fibroblast cell communication in heart failure. Nature 2024;1 -11.</cite> [<a href="https://doi.org/10.1038/s41586-024-08008-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12334188/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39443792/" class="usa-link">PubMed</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Ananthakrishnan A. The potential of immunotherapy treatments to facilitate post-cardiac injury recovery. J High School Sci. 2022;6(4).</cite>
</li>
<li id="CR66">
<span class="label">66.</span><cite> Tocchetti CG, Farmakis D, Koop Y, Andres MS, Couch LS, Formisano L, et al. Cardiovascular toxicities of immune therapies for cancer–a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology. Eur J Heart Fail. 2024.</cite> [<a href="https://doi.org/10.1002/ejhf.3340" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39087551/" class="usa-link">PubMed</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite> Amrute JM, Luo X, Penna V, Bredemeyer A, Yamawaki T, Heo GS. Targeting the immune-fibrosis axis in myocardial infarction and heart failure. bioRxiv. 2022;2022-10.</cite>
</li>
<li id="CR68">
<span class="label">68.</span><cite>Tillmanns J, Weiglein JM, Neuser J, Fraccarollo D, Galuppo P, König T, Diekmann J, Ross T, Bengel FM, Bauersachs J, Derlin T. Circulating soluble fibroblast activation protein (FAP) levels are independent of cardiac and extra-cardiac FAP expression determined by targeted molecular imaging in patients with myocardial FAP activation. Int J Cardiol. 2024;406:132044.
</cite> [<a href="https://doi.org/10.1016/j.ijcard.2024.132044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38614364/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tillmanns%20J,%20Weiglein%20JM,%20Neuser%20J,%20Fraccarollo%20D,%20Galuppo%20P,%20K%C3%B6nig%20T,%20Diekmann%20J,%20Ross%20T,%20Bengel%20FM,%20Bauersachs%20J,%20Derlin%20T.%20Circulating%20soluble%20fibroblast%20activation%20protein%20(FAP)%20levels%20are%20independent%20of%20cardiac%20and%20extra-cardiac%20FAP%20expression%20determined%20by%20targeted%20molecular%20imaging%20in%20patients%20with%20myocardial%20FAP%20activation.%20Int%20J%20Cardiol.%202024;406:132044." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Korell, F., Entenmann, L., Romann, S., Giannitsis, E., Schmitt, A., Müller-Tidow,C., … Lehmann, L. H. Evaluation of all-cause mortality and cardiovascular safety in patients receiving chimeric antigen receptor T cell therapy: a prospective cohort study. EClinicalMedicine, 69.</cite> [<a href="https://doi.org/10.1016/j.eclinm.2024.102504" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10965403/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38544797/" class="usa-link">PubMed</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Spoladore R, Falasconi G, Fiore G, Di Maio S, Preda A, Slavich M, Fragasso G. Cardiac fibrosis: emerging agents in preclinical and clinical development. Expert Opin Investig Drugs. 2021;30(2):153–66.
</cite> [<a href="https://doi.org/10.1080/13543784.2021.1868432" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33356660/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Spoladore%20R,%20Falasconi%20G,%20Fiore%20G,%20Di%20Maio%20S,%20Preda%20A,%20Slavich%20M,%20Fragasso%20G.%20Cardiac%20fibrosis:%20emerging%20agents%20in%20preclinical%20and%20clinical%20development.%20Expert%20Opin%20Investig%20Drugs.%202021;30(2):153%E2%80%9366." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>Wang JY, Wang L. CAR-T cell therapy: where are we now, and where are we heading? Blood Sci. 2023;5(04):237–48.
</cite> [<a href="https://doi.org/10.1097/BS9.0000000000000173" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10629745/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37941917/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20JY,%20Wang%20L.%20CAR-T%20cell%20therapy:%20where%20are%20we%20now,%20and%20where%20are%20we%20heading?%20Blood%20Sci.%202023;5(04):237%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Lundberg IE, Galindo-Feria AS, Horuluoglu B. CD19-targeting CAR T-cell therapy for antisynthetase syndrome. JAMA. 2023;329(24):2130–1.
</cite> [<a href="https://doi.org/10.1001/jama.2023.7240" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37367988/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lundberg%20IE,%20Galindo-Feria%20AS,%20Horuluoglu%20B.%20CD19-targeting%20CAR%20T-cell%20therapy%20for%20antisynthetase%20syndrome.%20JAMA.%202023;329(24):2130%E2%80%931." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Bengel, F., Epstein, J. A., Gropler, R., Haberkorn, U., Kramann, R., Lavine, K.,… Wu, H. Linking immune modulation to cardiac fibrosis. Nature Cardiovascular Research, 2024;3(4), 414–419.</cite> [<a href="https://doi.org/10.1038/s44161-024-00459-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12278716/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39196217/" class="usa-link">PubMed</a>]</li>
<li id="CR74">
<span class="label">74.</span><cite>Kramann R, Schneider RK, DiRocco DP, Machado F, Fleig S, Bondzie PA, Henderson JM, Ebert BL, Humphreys BD. Perivascular Gli1 + progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell. 2015;16(1):51–66.
</cite> [<a href="https://doi.org/10.1016/j.stem.2014.11.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4289444/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25465115/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kramann%20R,%20Schneider%20RK,%20DiRocco%20DP,%20Machado%20F,%20Fleig%20S,%20Bondzie%20PA,%20Henderson%20JM,%20Ebert%20BL,%20Humphreys%20BD.%20Perivascular%20Gli1%E2%80%89+%E2%80%89progenitors%20are%20key%20contributors%20to%20injury-induced%20organ%20fibrosis.%20Cell%20Stem%20Cell.%202015;16(1):51%E2%80%9366." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR75">
<span class="label">75.</span><cite>Beatty GL, Haas AR, Maus MV, Torigian DA, Soulen MC, Plesa G, Chew A, Zhao Y, Levine BL, Albelda SM, Kalos M. Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce antitumor activity in solid malignancies. Cancer Immunol Res. 2014;2(2):112–20.
</cite> [<a href="https://doi.org/10.1158/2326-6066.CIR-13-0170" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3932715/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24579088/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Beatty%20GL,%20Haas%20AR,%20Maus%20MV,%20Torigian%20DA,%20Soulen%20MC,%20Plesa%20G,%20Chew%20A,%20Zhao%20Y,%20Levine%20BL,%20Albelda%20SM,%20Kalos%20M.%20Mesothelin-specific%20chimeric%20antigen%20receptor%20mRNA-engineered%20T%20cells%20induce%20antitumor%20activity%20in%20solid%20malignancies.%20Cancer%20Immunol%20Res.%202014;2(2):112%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR76">
<span class="label">76.</span><cite>Wu CY, Roybal KT, Puchner EM, Onuffer J, Lim WA. Remote control of therapeutic T cells through a small molecule–gated chimeric receptor. Science. 2015;350(6258):aab4077.
</cite> [<a href="https://doi.org/10.1126/science.aab4077" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4721629/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26405231/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20CY,%20Roybal%20KT,%20Puchner%20EM,%20Onuffer%20J,%20Lim%20WA.%20Remote%20control%20of%20therapeutic%20T%20cells%20through%20a%20small%20molecule%E2%80%93gated%20chimeric%20receptor.%20Science.%202015;350(6258):aab4077." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR77">
<span class="label">77.</span><cite>Zmievskaya E, Valiullina A, Ganeeva I, Petukhov A, Rizvanov A, Bulatov E. Application of CAR-T cell therapy beyond oncology: autoimmune diseases and viral infections. Biomedicines. 2021;9(1):59.
</cite> [<a href="https://doi.org/10.3390/biomedicines9010059" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7827151/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33435454/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zmievskaya%20E,%20Valiullina%20A,%20Ganeeva%20I,%20Petukhov%20A,%20Rizvanov%20A,%20Bulatov%20E.%20Application%20of%20CAR-T%20cell%20therapy%20beyond%20oncology:%20autoimmune%20diseases%20and%20viral%20infections.%20Biomedicines.%202021;9(1):59." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR78">
<span class="label">78.</span><cite>Liu Z, Xiao Y, Lyu J, Jing D, Liu L, Fu Y, Zhang C. The expanded application of CAR-T cell therapy for the treatment of multiple non-tumoral diseases. Protein Cell. 2024;15(9):633–41.
</cite> [<a href="https://doi.org/10.1093/procel/pwad061" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11365555/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38146589/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20Z,%20Xiao%20Y,%20Lyu%20J,%20Jing%20D,%20Liu%20L,%20Fu%20Y,%20Zhang%20C.%20The%20expanded%20application%20of%20CAR-T%20cell%20therapy%20for%20the%20treatment%20of%20multiple%20non-tumoral%20diseases.%20Protein%20Cell.%202024;15(9):633%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR79">
<span class="label">79.</span><cite>Zhang Q, Dai J, Liu T, Rao W, Li D, Gu Z, Huang L, Wang J, Hou X. Targeting cardiac fibrosis with chimeric antigen Receptor-Engineered cells. Molecular and cellular biochemistry. Oct. 2024;26:1–4.</cite> [<a href="https://doi.org/10.1007/s11010-024-05134-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39460827/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20Q,%20Dai%20J,%20Liu%20T,%20Rao%20W,%20Li%20D,%20Gu%20Z,%20Huang%20L,%20Wang%20J,%20Hou%20X.%20Targeting%20cardiac%20fibrosis%20with%20chimeric%20antigen%20Receptor-Engineered%20cells.%20Molecular%20and%20cellular%20biochemistry.%20Oct.%202024;26:1%E2%80%934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR80">
<span class="label">80.</span><cite>Dai H, Zhu C, Huai Q, Xu W, Zhu J, Zhang X, Wang H. Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models. J Hepatol. 2024;80(6):913–27.
</cite> [<a href="https://doi.org/10.1016/j.jhep.2024.01.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38340812/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dai%20H,%20Zhu%20C,%20Huai%20Q,%20Xu%20W,%20Zhu%20J,%20Zhang%20X,%20Wang%20H.%20Chimeric%20antigen%20receptor-modified%20macrophages%20ameliorate%20liver%20fibrosis%20in%20preclinical%20models.%20J%20Hepatol.%202024;80(6):913%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR81">
<span class="label">81.</span><cite>Şahin A, Babayev H, Gül M. FAP-targeted CAR T-cell therapy: A promising approach for the treatment of peyronie’s disease. Med Hypotheses. 2023;178:111130.</cite> [<a href="https://scholar.google.com/scholar_lookup?%C5%9Eahin%20A,%20Babayev%20H,%20G%C3%BCl%20M.%20FAP-targeted%20CAR%20T-cell%20therapy:%20A%20promising%20approach%20for%20the%20treatment%20of%20peyronie%E2%80%99s%20disease.%20Med%20Hypotheses.%202023;178:111130." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR82">
<span class="label">82.</span><cite>Globerson Levin A, Rivière I, Eshhar Z, Sadelain M. CAR T cells: Building on the CD19 paradigm. Eur J Immunol. 2021;51(9):2151–63.
</cite> [<a href="https://doi.org/10.1002/eji.202049064" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9392049/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34196410/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Globerson%20Levin%20A,%20Rivi%C3%A8re%20I,%20Eshhar%20Z,%20Sadelain%20M.%20CAR%20T%20cells:%20Building%20on%20the%20CD19%20paradigm.%20Eur%20J%20Immunol.%202021;51(9):2151%E2%80%9363." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR83">
<span class="label">83.</span><cite>Yoon S, Eom GH. Chimeric antigen receptor T cell therapy: a novel modality for immune modulation. Chonnam Med J. 2020;56(1):6–11.
</cite> [<a href="https://doi.org/10.4068/cmj.2020.56.1.6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6976774/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32021836/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yoon%20S,%20Eom%20GH.%20Chimeric%20antigen%20receptor%20T%20cell%20therapy:%20a%20novel%20modality%20for%20immune%20modulation.%20Chonnam%20Med%20J.%202020;56(1):6%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR84">
<span class="label">84.</span><cite>Ye B, Hu Y, Zhang M, Huang H. Research advance in lipid nanoparticle-mRNA delivery system and its application in CAR-T cell therapy. Zhejiang Da Xue Xue bao. Yi Xue ban = journal of Zhejiang university. Med Sci. 2022;51(2):185–91.</cite> [<a href="https://doi.org/10.3724/zdxbyxb-2022-0047" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9353640/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36161298/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ye%20B,%20Hu%20Y,%20Zhang%20M,%20Huang%20H.%20Research%20advance%20in%20lipid%20nanoparticle-mRNA%20delivery%20system%20and%20its%20application%20in%20CAR-T%20cell%20therapy.%20Zhejiang%20Da%20Xue%20Xue%20bao.%20Yi%20Xue%20ban%E2%80%89=%E2%80%89journal%20of%20Zhejiang%20university.%20Med%20Sci.%202022;51(2):185%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR85">
<span class="label">85.</span><cite>Huang S, de Jong D, P Das J, S Widemon R, Braumuller B, Paily J, M Capaccione K. Imaging the side effects of CAR T cell therapy: a primer for the practicing radiologist. Acad Radiol. 2023;30(11):2712–27.
</cite> [<a href="https://doi.org/10.1016/j.acra.2023.04.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37394411/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20S,%20de%20Jong%20D,%20P%20Das%20J,%20S%20Widemon%20R,%20Braumuller%20B,%20Paily%20J,%20M%20Capaccione%20K.%20Imaging%20the%20side%20effects%20of%20CAR%20T%20cell%20therapy:%20a%20primer%20for%20the%20practicing%20radiologist.%20Acad%20Radiol.%202023;30(11):2712%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR86">
<span class="label">86.</span><cite>Sun MY, Li W, Chen W. Chimeric antigen receptor T cell and regulatory T cell therapy in non-oncology diseases: A narrative review of studies from 2017 to 2023. Hum Vaccines Immunotherapeutics. 2023;19(2):2251839.</cite> [<a href="https://doi.org/10.1080/21645515.2023.2251839" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10566417/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37814513/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20MY,%20Li%20W,%20Chen%20W.%20Chimeric%20antigen%20receptor%20T%20cell%20and%20regulatory%20T%20cell%20therapy%20in%20non-oncology%20diseases:%20A%20narrative%20review%20of%20studies%20from%202017%20to%202023.%20Hum%20Vaccines%20Immunotherapeutics.%202023;19(2):2251839." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR87">
<span class="label">87.</span><cite>Mitra A, Barua A, Huang L, Ganguly S, Feng Q, He B. From bench to bedside: the history and progress of CAR T cell therapy. Front Immunol. 2023;14:1188049.
</cite> [<a href="https://doi.org/10.3389/fimmu.2023.1188049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10225594/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37256141/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mitra%20A,%20Barua%20A,%20Huang%20L,%20Ganguly%20S,%20Feng%20Q,%20He%20B.%20From%20bench%20to%20bedside:%20the%20history%20and%20progress%20of%20CAR%20T%20cell%20therapy.%20Front%20Immunol.%202023;14:1188049." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR88">
<span class="label">88.</span><cite>Jardin B, Epstein JA. Emerging mRNA therapies for cardiac fibrosis. Am J Physiology-Cell Physiol. 2024;326(1):C107–11.</cite> [<a href="https://doi.org/10.1152/ajpcell.00504.2023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11192469/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38047297/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jardin%20B,%20Epstein%20JA.%20Emerging%20mRNA%20therapies%20for%20cardiac%20fibrosis.%20Am%20J%20Physiology-Cell%20Physiol.%202024;326(1):C107%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR89">
<span class="label">89.</span><cite>Massaro M, Wu S, Baudo G, Liu H, Collum S, Lee H, Blanco E. Lipid nanoparticle-mediated mRNA delivery in lung fibrosis. Eur J Pharm Sci. 2023;183:106370.
</cite> [<a href="https://doi.org/10.1016/j.ejps.2023.106370" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10898324/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36642345/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Massaro%20M,%20Wu%20S,%20Baudo%20G,%20Liu%20H,%20Collum%20S,%20Lee%20H,%20Blanco%20E.%20Lipid%20nanoparticle-mediated%20mRNA%20delivery%20in%20lung%20fibrosis.%20Eur%20J%20Pharm%20Sci.%202023;183:106370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR90">
<span class="label">90.</span><cite>Soroudi S, Jaafari MR, Arabi L. Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: advances in genome editing and CAR T cell therapy. J Controlled Release. 2024;372:113–40.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2024.06.023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38876358/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Soroudi%20S,%20Jaafari%20MR,%20Arabi%20L.%20Lipid%20nanoparticle%20(LNP)%20mediated%20mRNA%20delivery%20in%20cardiovascular%20diseases:%20advances%20in%20genome%20editing%20and%20CAR%20T%20cell%20therapy.%20J%20Controlled%20Release.%202024;372:113%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR91">
<span class="label">91.</span><cite>Evers, M. J., Du, W., Yang, Q., Kooijmans, S. A., Vink, A., van Steenbergen, M.,… Schiffelers, R. Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles. Journal of Controlled Release, 2022;343, 207–216.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2022.01.027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35077739/" class="usa-link">PubMed</a>]</li>
<li id="CR92">
<span class="label">92.</span><cite>Wang QZ, Wang ZM, Huang ZY, Ge JB. Direct in vivo cardiac reprogramming with circular RNA of single transcription factor delivered by fibroblast-targeting lipid nanoparticles. Eur Heart J. 2024;45(Supplement1):ehae666–3734.</cite> [<a href="https://scholar.google.com/scholar_lookup?Wang%20QZ,%20Wang%20ZM,%20Huang%20ZY,%20Ge%20JB.%20Direct%20in%20vivo%20cardiac%20reprogramming%20with%20circular%20RNA%20of%20single%20transcription%20factor%20delivered%20by%20fibroblast-targeting%20lipid%20nanoparticles.%20Eur%20Heart%20J.%202024;45(Supplement1):ehae666%E2%80%933734." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR93">
<span class="label">93.</span><cite>Labonia MCI, Senti ME, van der Kraak PH, Brans MAD, Dokter I, Streef TJ, Vader P. Cardiac delivery of modified mRNA using lipid nanoparticles: cellular targets and biodistribution after intramyocardial administration. J Controlled Release. 2024;369:734–45.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2024.04.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38604385/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Labonia%20MCI,%20Senti%20ME,%20van%20der%20Kraak%20PH,%20Brans%20MAD,%20Dokter%20I,%20Streef%20TJ,%20Vader%20P.%20Cardiac%20delivery%20of%20modified%20mRNA%20using%20lipid%20nanoparticles:%20cellular%20targets%20and%20biodistribution%20after%20intramyocardial%20administration.%20J%20Controlled%20Release.%202024;369:734%E2%80%9345." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR94">
<span class="label">94.</span><cite>Cheng M, Yu X, Qi S, Yang K, Lu M, Cao F, Yu G. (2024). Development of organ targeting lipid nanoparticles with low immunogenicity and their application in the treatment of pulmonary fibrosis. Angew Chem, 136(44), e202407398.</cite> [<a href="https://doi.org/10.1002/anie.202407398" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39082226/" class="usa-link">PubMed</a>]</li>
<li id="CR95">
<span class="label">95.</span><cite>Mainkar G, Yoo J, Zak MZ, Kurian AA, Adjmi M, Zangi L. Specific modified mRNA translation system (SMRTS) for the Attenuation of pulmonary fibrosis. A68. Unveiling novel avenues in ipf therapies. American Thoracic Society; 2024;A2468-A2468.</cite>
</li>
<li id="CR96">
<span class="label">96.</span><cite>Zhu D, Liu S, Huang K, Li J, Mei X, Li Z, Cheng K. Intrapericardial long non-coding RNA–Tcf21 antisense RNA inducing demethylation administration promotes cardiac repair. Eur Heart J. 2023;44(19):1748–60.
</cite> [<a href="https://doi.org/10.1093/eurheartj/ehad114" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10411945/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36916305/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhu%20D,%20Liu%20S,%20Huang%20K,%20Li%20J,%20Mei%20X,%20Li%20Z,%20Cheng%20K.%20Intrapericardial%20long%20non-coding%20RNA%E2%80%93Tcf21%20antisense%20RNA%20inducing%20demethylation%20administration%20promotes%20cardiac%20repair.%20Eur%20Heart%20J.%202023;44(19):1748%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR97">
<span class="label">97.</span><cite>Bartneck M. Lipid nanoparticle formulations for targeting leukocytes with therapeutic RNA in liver fibrosis. Adv Drug Deliv Rev. 2021;173:70–88.
</cite> [<a href="https://doi.org/10.1016/j.addr.2021.03.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33774114/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bartneck%20M.%20Lipid%20nanoparticle%20formulations%20for%20targeting%20leukocytes%20with%20therapeutic%20RNA%20in%20liver%20fibrosis.%20Adv%20Drug%20Deliv%20Rev.%202021;173:70%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR98">
<span class="label">98.</span><cite>Huntington J, Pachauri M, Ali H, Giacca M. RNA interference therapeutics for cardiac regeneration. Curr Opin Genet Dev. 2021;70:48–53.
</cite> [<a href="https://doi.org/10.1016/j.gde.2021.05.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34098251/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huntington%20J,%20Pachauri%20M,%20Ali%20H,%20Giacca%20M.%20RNA%20interference%20therapeutics%20for%20cardiac%20regeneration.%20Curr%20Opin%20Genet%20Dev.%202021;70:48%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR99">
<span class="label">99.</span><cite>Wang Y, Wu M, Guo H. Modified mRNA as a treatment for myocardial infarction. Int J Mol Sci. 2023;24(5):4737.
</cite> [<a href="https://doi.org/10.3390/ijms24054737" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10003380/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36902165/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Wu%20M,%20Guo%20H.%20Modified%20mRNA%20as%20a%20treatment%20for%20myocardial%20infarction.%20Int%20J%20Mol%20Sci.%202023;24(5):4737." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR100">
<span class="label">100.</span><cite>Stratton MS, McKinsey TA. Epigenetic regulation of cardiac fibrosis. J Mol Cell Cardiol. 2016;92:206–13.
</cite> [<a href="https://doi.org/10.1016/j.yjmcc.2016.02.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4987078/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26876451/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Stratton%20MS,%20McKinsey%20TA.%20Epigenetic%20regulation%20of%20cardiac%20fibrosis.%20J%20Mol%20Cell%20Cardiol.%202016;92:206%E2%80%9313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR101">
<span class="label">101.</span><cite>Felisbino MB, McKinsey TA. Epigenetics in cardiac fibrosis: emphasis on inflammation and fibroblast activation. JACC: Basic Translational Sci. 2018;3(5):704–15.</cite> [<a href="https://doi.org/10.1016/j.jacbts.2018.05.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6234501/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30456341/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Felisbino%20MB,%20McKinsey%20TA.%20Epigenetics%20in%20cardiac%20fibrosis:%20emphasis%20on%20inflammation%20and%20fibroblast%20activation.%20JACC:%20Basic%20Translational%20Sci.%202018;3(5):704%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR102">
<span class="label">102.</span><cite>Alizadeh D, Wong RA, Yang X, Wang D, Pecoraro JR, Kuo CF, Aguilar B, Qi Y, Ann DK, Starr R, Urak R. IL15 enhances CAR-T cell antitumor activity by reducing mTORC1 activity and preserving their stem cell memory phenotype. Cancer Immunol Res. 2019;7(5):759–72.
</cite> [<a href="https://doi.org/10.1158/2326-6066.CIR-18-0466" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6687561/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30890531/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alizadeh%20D,%20Wong%20RA,%20Yang%20X,%20Wang%20D,%20Pecoraro%20JR,%20Kuo%20CF,%20Aguilar%20B,%20Qi%20Y,%20Ann%20DK,%20Starr%20R,%20Urak%20R.%20IL15%20enhances%20CAR-T%20cell%20antitumor%20activity%20by%20reducing%20mTORC1%20activity%20and%20preserving%20their%20stem%20cell%20memory%20phenotype.%20Cancer%20Immunol%20Res.%202019;7(5):759%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR103">
<span class="label">103.</span><cite>Catino AB. Cytokines are at the heart of it: cytokine release syndrome underlies cardiovascular effects of CAR T cell. Cardio Oncol. 2020;2(2):204–6.</cite> [<a href="https://doi.org/10.1016/j.jaccao.2020.05.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8352284/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34396229/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Catino%20AB.%20Cytokines%20are%20at%20the%20heart%20of%20it:%20cytokine%20release%20syndrome%20underlies%20cardiovascular%20effects%20of%20CAR%20T%20cell.%20Cardio%20Oncol.%202020;2(2):204%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR104">
<span class="label">104.</span><cite>Asnani A. Cardiotoxicity of immunotherapy: incidence, diagnosis, and management. Curr Oncol Rep. 2018;20:1–7.
</cite> [<a href="https://doi.org/10.1007/s11912-018-0690-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29644505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Asnani%20A.%20Cardiotoxicity%20of%20immunotherapy:%20incidence,%20diagnosis,%20and%20management.%20Curr%20Oncol%20Rep.%202018;20:1%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR105">
<span class="label">105.</span><cite>Simbaqueba CC, Aponte MP, Kim P, Deswal A, Palaskas NL, Iliescu C, Lopez-Mattei J. Cardiovascular complications of chimeric antigen receptor T-cell therapy: the cytokine release syndrome and associated arrhythmias. J Immunotherapy Precision Oncol. 2020;3(3):113–20.</cite> [<a href="https://doi.org/10.36401/JIPO-20-10" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9165578/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35663258/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Simbaqueba%20CC,%20Aponte%20MP,%20Kim%20P,%20Deswal%20A,%20Palaskas%20NL,%20Iliescu%20C,%20Lopez-Mattei%20J.%20Cardiovascular%20complications%20of%20chimeric%20antigen%20receptor%20T-cell%20therapy:%20the%20cytokine%20release%20syndrome%20and%20associated%20arrhythmias.%20J%20Immunotherapy%20Precision%20Oncol.%202020;3(3):113%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR106">
<span class="label">106.</span><cite>Dal’bo N, Patel R, Parikh R, Shah SP, Guha A, Dani SS, Ganatra S. Cardiotoxicity of contemporary anticancer immunotherapy. Curr Treat Options Cardiovasc Med. 2020;22:1–15.
</cite> [<a href="https://doi.org/10.1007/s11936-020-00867-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7605901/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33162729/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dal%E2%80%99bo%20N,%20Patel%20R,%20Parikh%20R,%20Shah%20SP,%20Guha%20A,%20Dani%20SS,%20Ganatra%20S.%20Cardiotoxicity%20of%20contemporary%20anticancer%20immunotherapy.%20Curr%20Treat%20Options%20Cardiovasc%20Med.%202020;22:1%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR107">
<span class="label">107.</span><cite>Ganatra S, Dani SS, Yang EH, Zaha VG, Nohria A. Cardiotoxicity of T-cell antineoplastic therapies: JACC: cardiooncology primer. Cardio Oncol. 2022;4(5):616–23.</cite> [<a href="https://doi.org/10.1016/j.jaccao.2022.07.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9830211/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36636447/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ganatra%20S,%20Dani%20SS,%20Yang%20EH,%20Zaha%20VG,%20Nohria%20A.%20Cardiotoxicity%20of%20T-cell%20antineoplastic%20therapies:%20JACC:%20cardiooncology%20primer.%20Cardio%20Oncol.%202022;4(5):616%E2%80%9323." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR108">
<span class="label">108.</span><cite>Yamauchi-Takihara K. gp130-mediated pathway and heart failure. Future Cardiol. 2008;4(4):427–37.
</cite> [<a href="https://doi.org/10.2217/14796678.4.4.427" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19804322/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yamauchi-Takihara%20K.%20gp130-mediated%20pathway%20and%20heart%20failure.%20Future%20Cardiol.%202008;4(4):427%E2%80%9337." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR109">
<span class="label">109.</span><cite>Gregolin CS, do Nascimento M, de Souza SL, Mota GA, Bomfim GF, Luvizotto RD, Sugizaki MM, Bazan SG, de Campos DH, Dias MC, Correa CR. Myocardial dysfunction in cirrhotic cardiomyopathy is associated with alterations of phospholamban phosphorylation and IL-6 levels. Arch Med Res. 2021;52(3):284–93.
</cite> [<a href="https://doi.org/10.1016/j.arcmed.2020.11.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33220932/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gregolin%20CS,%20do%20Nascimento%20M,%20de%20Souza%20SL,%20Mota%20GA,%20Bomfim%20GF,%20Luvizotto%20RD,%20Sugizaki%20MM,%20Bazan%20SG,%20de%20Campos%20DH,%20Dias%20MC,%20Correa%20CR.%20Myocardial%20dysfunction%20in%20cirrhotic%20cardiomyopathy%20is%20associated%20with%20alterations%20of%20phospholamban%20phosphorylation%20and%20IL-6%20levels.%20Arch%20Med%20Res.%202021;52(3):284%E2%80%9393." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR110">
<span class="label">110.</span><cite>Afzal A, Farooque U, Gillies E, Hassell L. T-cell therapy-mediated myocarditis secondary to cytokine release syndrome. Cureus, 2020;12(8).</cite> [<a href="https://doi.org/10.7759/cureus.10022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7515743/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32983717/" class="usa-link">PubMed</a>]</li>
<li id="CR111">
<span class="label">111.</span><cite>Burns EA, Gentille C, Trachtenberg B, Pingali SR, Anand K. Cardiotoxicity associated with anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy: recognition, risk factors, and management. Diseases. 2021;9(1):20.
</cite> [<a href="https://doi.org/10.3390/diseases9010020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8006027/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33802788/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Burns%20EA,%20Gentille%20C,%20Trachtenberg%20B,%20Pingali%20SR,%20Anand%20K.%20Cardiotoxicity%20associated%20with%20anti-CD19%20chimeric%20antigen%20receptor%20T-cell%20(CAR-T)%20therapy:%20recognition,%20risk%20factors,%20and%20management.%20Diseases.%202021;9(1):20." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR112">
<span class="label">112.</span><cite>Maleki S, Esmaeili Z, Seighali N, Shafiee A, Namin SM, Zavareh MAT, Hosseini K. Cardiac adverse events after chimeric antigen receptor (CAR) T cell therapies: an updated systematic review and meta-analysis. Cardio-Oncology. 2024;10(1):52.
</cite> [<a href="https://doi.org/10.1186/s40959-024-00252-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11334556/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39164789/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maleki%20S,%20Esmaeili%20Z,%20Seighali%20N,%20Shafiee%20A,%20Namin%20SM,%20Zavareh%20MAT,%20Hosseini%20K.%20Cardiac%20adverse%20events%20after%20chimeric%20antigen%20receptor%20(CAR)%20T%20cell%20therapies:%20an%20updated%20systematic%20review%20and%20meta-analysis.%20Cardio-Oncology.%202024;10(1):52." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR113">
<span class="label">113.</span><cite>Tvedt THA, Vo AK, Bruserud Ø, Reikvam H. Cytokine release syndrome in the immunotherapy of hematological malignancies: the biology behind and possible clinical consequences. J Clin Med. 2021;10(21):5190.
</cite> [<a href="https://doi.org/10.3390/jcm10215190" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8585070/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34768710/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tvedt%20THA,%20Vo%20AK,%20Bruserud%20%C3%98,%20Reikvam%20H.%20Cytokine%20release%20syndrome%20in%20the%20immunotherapy%20of%20hematological%20malignancies:%20the%20biology%20behind%20and%20possible%20clinical%20consequences.%20J%20Clin%20Med.%202021;10(21):5190." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR114">
<span class="label">114.</span><cite>Esposito, R., Fedele, T., Orefice, S., Cuomo, V., Prastaro, M., Canonico, M. E.,… Esposito, G. An emergent form of cardiotoxicity: acute myocarditis induced by immune checkpoint inhibitors. Biomolecules, 2021;11(6), 785.</cite> [<a href="https://doi.org/10.3390/biom11060785" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8224544/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34067474/" class="usa-link">PubMed</a>]</li>
<li id="CR115">
<span class="label">115.</span><cite>Galani J, Gupta T, Waheed N, Sennhauser S, Abdou M. Cytokine release syndrome mediated myocarditis: a rare complication of chimeric antigen receptor T-cell therapy. J Card Fail. 2024;30(1):255.</cite> [<a href="https://scholar.google.com/scholar_lookup?Galani%20J,%20Gupta%20T,%20Waheed%20N,%20Sennhauser%20S,%20Abdou%20M.%20Cytokine%20release%20syndrome%20mediated%20myocarditis:%20a%20rare%20complication%20of%20chimeric%20antigen%20receptor%20T-cell%20therapy.%20J%20Card%20Fail.%202024;30(1):255." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR116">
<span class="label">116.</span><cite>Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns,B., … Thavendiranathan, P. Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC). European Heart Journal, 2022;43, 4229–4361.</cite>
</li>
<li id="CR117">
<span class="label">117.</span><cite>Quagliariello, V., Paccone, A., Iovine, M., Cavalcanti, E., Berretta, M., Maurea,C., … Maurea, N. Interleukin-1 blocking agents as promising strategy for prevention of anticancer drug-induced cardiotoxicities: possible implications in cancer patients with COVID-19. European Review for Medical &amp; Pharmacological Sciences, 2021;25(21).</cite> [<a href="https://doi.org/10.26355/eurrev_202111_27124" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34787884/" class="usa-link">PubMed</a>]</li>
<li id="CR118">
<span class="label">118.</span><cite>Haybar H, Shahrabi S, Zayeri ZD, Pezeshki S. Strategies to increase cardioprotection through cardioprotective chemokines in chemotherapy-induced cardiotoxicity. Int J Cardiol. 2018;269:276–82.
</cite> [<a href="https://doi.org/10.1016/j.ijcard.2018.07.087" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30054148/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Haybar%20H,%20Shahrabi%20S,%20Zayeri%20ZD,%20Pezeshki%20S.%20Strategies%20to%20increase%20cardioprotection%20through%20cardioprotective%20chemokines%20in%20chemotherapy-induced%20cardiotoxicity.%20Int%20J%20Cardiol.%202018;269:276%E2%80%9382." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR119">
<span class="label">119.</span><cite>Ganatra S, Parikh R, Neilan TG. Cardiotoxicity of immune therapy. Cardiol Clin. 2019;37(4):385–97.
</cite> [<a href="https://doi.org/10.1016/j.ccl.2019.07.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31587780/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ganatra%20S,%20Parikh%20R,%20Neilan%20TG.%20Cardiotoxicity%20of%20immune%20therapy.%20Cardiol%20Clin.%202019;37(4):385%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR120">
<span class="label">120.</span><cite>Camilli M, Viscovo M, Felici T, Maggio L, Ballacci F, Carella G, Minotti G. Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study. Cardio-Oncology. 2024;10(1):18.
</cite> [<a href="https://doi.org/10.1186/s40959-024-00218-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10967131/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38532515/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Camilli%20M,%20Viscovo%20M,%20Felici%20T,%20Maggio%20L,%20Ballacci%20F,%20Carella%20G,%20Minotti%20G.%20Inflammation%20and%20acute%20cardiotoxicity%20in%20adult%20hematological%20patients%20treated%20with%20CAR-T%20cells:%20results%20from%20a%20pilot%20proof-of-concept%20study.%20Cardio-Oncology.%202024;10(1):18." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR121">
<span class="label">121.</span><cite>Stein-Merlob AF, Rothberg MV, Ribas A, Yang EH. Cardiotoxicities of novel cancer immunotherapies. Heart. 2021;107(21):1694–703.
</cite> [<a href="https://doi.org/10.1136/heartjnl-2020-318083" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33722826/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Stein-Merlob%20AF,%20Rothberg%20MV,%20Ribas%20A,%20Yang%20EH.%20Cardiotoxicities%20of%20novel%20cancer%20immunotherapies.%20Heart.%202021;107(21):1694%E2%80%93703." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR122">
<span class="label">122.</span><cite>Ganatra S, Carver JR, Hayek SS, Ky B, Leja MJ, Lenihan DJ, Lenneman C, Mousavi N, Park JH, Perales MA, Ryan TD. Chimeric antigen receptor T-cell therapy for cancer and heart: JACC Council perspectives. J Am Coll Cardiol. 2019;74(25):3153–63.
</cite> [<a href="https://doi.org/10.1016/j.jacc.2019.10.049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8211027/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31856973/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ganatra%20S,%20Carver%20JR,%20Hayek%20SS,%20Ky%20B,%20Leja%20MJ,%20Lenihan%20DJ,%20Lenneman%20C,%20Mousavi%20N,%20Park%20JH,%20Perales%20MA,%20Ryan%20TD.%20Chimeric%20antigen%20receptor%20T-cell%20therapy%20for%20cancer%20and%20heart:%20JACC%20Council%20perspectives.%20J%20Am%20Coll%20Cardiol.%202019;74(25):3153%E2%80%9363." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR123">
<span class="label">123.</span><cite>Kochenderfer JN, Somerville RPT, Lu T, et al. Lymphoma remissions caused by Anti-CD19 chimeric antigen receptor T cells are associated with high serum Interleukin-15 levels. J Clin Oncol. 2017;35:1803–13.
</cite> [<a href="https://doi.org/10.1200/JCO.2016.71.3024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5455597/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28291388/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kochenderfer%20JN,%20Somerville%20RPT,%20Lu%20T,%20et%20al.%20Lymphoma%20remissions%20caused%20by%20Anti-CD19%20chimeric%20antigen%20receptor%20T%20cells%20are%20associated%20with%20high%20serum%20Interleukin-15%20levels.%20J%20Clin%20Oncol.%202017;35:1803%E2%80%9313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR124">
<span class="label">124.</span><cite>Totzeck M, Michel L, Lin Y, Herrmann J, Rassaf T. Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignancies. Eur Heart J. 2022;43(20):1928–40.
</cite> [<a href="https://doi.org/10.1093/eurheartj/ehac106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9123242/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35257157/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Totzeck%20M,%20Michel%20L,%20Lin%20Y,%20Herrmann%20J,%20Rassaf%20T.%20Cardiotoxicity%20from%20chimeric%20antigen%20receptor-T%20cell%20therapy%20for%20advanced%20malignancies.%20Eur%20Heart%20J.%202022;43(20):1928%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR125">
<span class="label">125.</span><cite>Mazetto RA, Monteiro SO, Bulhões E, Defante ML, Antunes VL, Balieiro CC, Feitoza L, Ferreira AL, Carvalho AM, Guida C. The cardiotoxic effects of CAR-T cell therapy: an updated systematic review and meta‐analysis. Eur J Haematol. 2024;113(6):798–809.
</cite> [<a href="https://doi.org/10.1111/ejh.14289" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39171519/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mazetto%20RA,%20Monteiro%20SO,%20Bulh%C3%B5es%20E,%20Defante%20ML,%20Antunes%20VL,%20Balieiro%20CC,%20Feitoza%20L,%20Ferreira%20AL,%20Carvalho%20AM,%20Guida%20C.%20The%20cardiotoxic%20effects%20of%20CAR-T%20cell%20therapy:%20an%20updated%20systematic%20review%20and%20meta%E2%80%90analysis.%20Eur%20J%20Haematol.%202024;113(6):798%E2%80%93809." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR126">
<span class="label">126.</span><cite>Patel NP, Dalal PJ, Meng Z, Baldridge AS, Cascino GJ, Sunderraj A, Sinha A, Karmali R, Feinstein MJ, Akhter N. Myocardial strain is associated with adverse cardiac events in patients treated with chimeric antigen receptor (CAR) T-cell therapy. Eur J Haematol. 2024;112(1):102–10.
</cite> [<a href="https://doi.org/10.1111/ejh.14088" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37649240/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Patel%20NP,%20Dalal%20PJ,%20Meng%20Z,%20Baldridge%20AS,%20Cascino%20GJ,%20Sunderraj%20A,%20Sinha%20A,%20Karmali%20R,%20Feinstein%20MJ,%20Akhter%20N.%20Myocardial%20strain%20is%20associated%20with%20adverse%20cardiac%20events%20in%20patients%20treated%20with%20chimeric%20antigen%20receptor%20(CAR)%20T-cell%20therapy.%20Eur%20J%20Haematol.%202024;112(1):102%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR127">
<span class="label">127.</span><cite>Ghosh AK, Chen DH, Guha A, Mackenzie S, Walker JM, Roddie C. CAR T cell therapy–related cardiovascular outcomes and management: systemic disease or direct cardiotoxicity? Cardio Oncol. 2020;2(1):97–109.</cite> [<a href="https://doi.org/10.1016/j.jaccao.2020.02.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8352125/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34396213/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ghosh%20AK,%20Chen%20DH,%20Guha%20A,%20Mackenzie%20S,%20Walker%20JM,%20Roddie%20C.%20CAR%20T%20cell%20therapy%E2%80%93related%20cardiovascular%20outcomes%20and%20management:%20systemic%20disease%20or%20direct%20cardiotoxicity?%20Cardio%20Oncol.%202020;2(1):97%E2%80%93109." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR128">
<span class="label">128.</span><cite>Patel NP, Doukas PG, Gordon LI, Akhter N. Cardiovascular toxicities of CAR T-cell therapy. Curr Oncol Rep. 2021;23:1–10.</cite> [<a href="https://doi.org/10.1007/s11912-021-01068-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33937946/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Patel%20NP,%20Doukas%20PG,%20Gordon%20LI,%20Akhter%20N.%20Cardiovascular%20toxicities%20of%20CAR%20T-cell%20therapy.%20Curr%20Oncol%20Rep.%202021;23:1%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR129">
<span class="label">129.</span><cite>Lipe, D. N., Rajha, E., Wechsler, A. H., Gaeta, S., Palaskas, N. L., Alhajji, Z.,… Chaftari, P. Cardiotoxicity associated with immune checkpoint inhibitors and CAR T-cell therapy. The American Journal of Emergency Medicine, 2021;50, 51–58.</cite> [<a href="https://doi.org/10.1016/j.ajem.2021.07.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34274878/" class="usa-link">PubMed</a>]</li>
<li id="CR130">
<span class="label">130.</span><cite>Hanna, K. S., Kaur, H., Alazzeh, M. S., Thandavaram, A., Channar, A., Purohit, A.,… Mohammed, L. Cardiotoxicity associated with chimeric antigen receptor (CAR)-T cell therapy for hematologic malignancies: A systematic review. Cureus, 2022;14(8).</cite> [<a href="https://doi.org/10.7759/cureus.28162" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9482759/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36148204/" class="usa-link">PubMed</a>]</li>
<li id="CR131">
<span class="label">131.</span><cite>Koch, C., Montrasio, G., Scherr, B. F., Schimmer, R., Matter, C. M., Bühler, K. P.,… Müller, A. M. (2022). Fulminant Cardiotoxicity in a Patient With Cardiac Lymphoma Treated With CAR-T Cells. Cardio Oncology, 4(5), 708–712.</cite> [<a href="https://doi.org/10.1016/j.jaccao.2022.07.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9830210/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36636430/" class="usa-link">PubMed</a>]</li>
<li id="CR132">
<span class="label">132.</span><cite>Mazetto, R. A., Monteiro, S. O., Bulhões, E., Defante, M. L., Antunes, V. L., Balieiro,C. C. A., … Guida, C. The cardiotoxic effects of CAR-T cell therapy: An updated systematic review and meta‐analysis. European Journal of Haematology.</cite> [<a href="https://doi.org/10.1111/ejh.14289" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39171519/" class="usa-link">PubMed</a>]</li>
<li id="CR133">
<span class="label">133.</span><cite>Lefebvre B, Kang Y, Smith AM, Frey NV, Carver JR, Scherrer-Crosbie M. Cardiovascular effects of CAR T cell therapy: a retrospective study. Cardio Oncol. 2020;2(2):193–203.</cite> [<a href="https://doi.org/10.1016/j.jaccao.2020.04.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7413146/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32776016/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lefebvre%20B,%20Kang%20Y,%20Smith%20AM,%20Frey%20NV,%20Carver%20JR,%20Scherrer-Crosbie%20M.%20Cardiovascular%20effects%20of%20CAR%20T%20cell%20therapy:%20a%20retrospective%20study.%20Cardio%20Oncol.%202020;2(2):193%E2%80%93203." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR134">
<span class="label">134.</span><cite>Patel M, Hudson O, Han J, Kondapalli L, Arora G, Hawi R, Lenneman C. Update on immunotherapy cardiotoxicity: checkpoint inhibitors, CAR T, and beyond. Curr Treat Options Oncol. 2023;24(11):1489–503.
</cite> [<a href="https://doi.org/10.1007/s11864-023-01130-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37624557/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Patel%20M,%20Hudson%20O,%20Han%20J,%20Kondapalli%20L,%20Arora%20G,%20Hawi%20R,%20Lenneman%20C.%20Update%20on%20immunotherapy%20cardiotoxicity:%20checkpoint%20inhibitors,%20CAR%20T,%20and%20beyond.%20Curr%20Treat%20Options%20Oncol.%202023;24(11):1489%E2%80%93503." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR135">
<span class="label">135.</span><cite>Montisci A, Vietri MT, Palmieri V, Sala S, Donatelli F, Napoli C. Cardiac toxicity associated with cancer immunotherapy and biological drugs. Cancers. 2021;13(19):4797.
</cite> [<a href="https://doi.org/10.3390/cancers13194797" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8508330/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34638281/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Montisci%20A,%20Vietri%20MT,%20Palmieri%20V,%20Sala%20S,%20Donatelli%20F,%20Napoli%20C.%20Cardiac%20toxicity%20associated%20with%20cancer%20immunotherapy%20and%20biological%20drugs.%20Cancers.%202021;13(19):4797." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR136">
<span class="label">136.</span><cite>Nenna A, Carpenito M, Chello C, Nappi P, Annibali O, Vincenzi B, Nappi F. Cardiotoxicity of chimeric antigen receptor T-cell (CAR-T) therapy: pathophysiology,clinical implications, and echocardiographic assessment. Int J Mol Sci. 2022;23(15):8242.
</cite> [<a href="https://doi.org/10.3390/ijms23158242" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9368621/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35897819/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nenna%20A,%20Carpenito%20M,%20Chello%20C,%20Nappi%20P,%20Annibali%20O,%20Vincenzi%20B,%20Nappi%20F.%20Cardiotoxicity%20of%20chimeric%20antigen%20receptor%20T-cell%20(CAR-T)%20therapy:%20pathophysiology,clinical%20implications,%20and%20echocardiographic%20assessment.%20Int%20J%20Mol%20Sci.%202022;23(15):8242." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR137">
<span class="label">137.</span><cite>Maleki, S., Esmaeili, Z., Seighali, N., Shafiee, A., Namin, S. M., Zavareh, M. A.T., … Hosseini, K. (2024). Cardiac adverse events after Chimeric Antigen Receptor(CAR) T cell therapies: an updated systematic review and meta-analysis. Cardio-Oncology,10(1), 52.</cite> [<a href="https://doi.org/10.1186/s40959-024-00252-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11334556/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39164789/" class="usa-link">PubMed</a>]</li>
<li id="CR138">
<span class="label">138.</span><cite>Herrmann J. Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia. Nat Reviews Cardiol. 2020;17(8):474–502.</cite> [<a href="https://doi.org/10.1038/s41569-020-0348-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8782611/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32231332/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Herrmann%20J.%20Adverse%20cardiac%20effects%20of%20cancer%20therapies:%20cardiotoxicity%20and%20arrhythmia.%20Nat%20Reviews%20Cardiol.%202020;17(8):474%E2%80%93502." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR139">
<span class="label">139.</span><cite>Karthikeyan B, Sunder SS, Puzanov I, Olejniczak SH, Pokharel S, Sharma UC. Cardiotoxic profiles of CAR-T therapy and bispecific T-cell engagers in hematological cancers. Commun Med. 2024;4(1):116.
</cite> [<a href="https://doi.org/10.1038/s43856-024-00540-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11176393/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38871977/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Karthikeyan%20B,%20Sunder%20SS,%20Puzanov%20I,%20Olejniczak%20SH,%20Pokharel%20S,%20Sharma%20UC.%20Cardiotoxic%20profiles%20of%20CAR-T%20therapy%20and%20bispecific%20T-cell%20engagers%20in%20hematological%20cancers.%20Commun%20Med.%202024;4(1):116." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR140">
<span class="label">140.</span><cite>Camilli M, Maggio L, Tinti L, Lamendola P, Lanza GA, Crea F, Lombardo A. Chimeric antigen receptor-T cell therapy-related cardiotoxicity in adults and children cancer patients: A clinical appraisal. Front Cardiovasc Med. 2023;10:1090103.
</cite> [<a href="https://doi.org/10.3389/fcvm.2023.1090103" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9988907/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36895831/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Camilli%20M,%20Maggio%20L,%20Tinti%20L,%20Lamendola%20P,%20Lanza%20GA,%20Crea%20F,%20Lombardo%20A.%20Chimeric%20antigen%20receptor-T%20cell%20therapy-related%20cardiotoxicity%20in%20adults%20and%20children%20cancer%20patients:%20A%20clinical%20appraisal.%20Front%20Cardiovasc%20Med.%202023;10:1090103." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR141">
<span class="label">141.</span><cite>Akbari B, Ghahri-Saremi N, Soltantoyeh T, Hadjati J, Ghassemi S, Mirzaei HR. Epigenetic strategies to boost CAR T cell therapy. Mol Ther. 2021;29(9):2640–59.
</cite> [<a href="https://doi.org/10.1016/j.ymthe.2021.08.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8417511/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34365035/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Akbari%20B,%20Ghahri-Saremi%20N,%20Soltantoyeh%20T,%20Hadjati%20J,%20Ghassemi%20S,%20Mirzaei%20HR.%20Epigenetic%20strategies%20to%20boost%20CAR%20T%20cell%20therapy.%20Mol%20Ther.%202021;29(9):2640%E2%80%9359." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Cardio-oncology are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s40959-025-00367-w"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/40959_2025_Article_367.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.6 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12372244/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12372244/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372244%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372244/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12372244/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12372244/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40847431/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12372244/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40847431/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12372244/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12372244/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="yR7NCHEpr0kg0amK2xVFtXHoEw4QyAkSCaDxyyhNEddFVhivp3tzspKqiqRHpqok">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
